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VOORWOORD: 
Dit onderzoek maakte deel uit van het onderzoeksprogramma 
"kwantitatieve morfologie, celbiologie en epidemiologie van 
( pre-)maligne afwijkingen". Het betrof een samenwerkingspro-
ject van de afdeling Urologie (hoofd Prof. Dr. F.M.J. De-
bruyne) en de afdeling Pathologische Anatomie (hoofd Prof. 
Dr. G.P. Vooys). 
De uiteindelijke afronding van het manuscript van dit proef-
schrift kwam tot stand tijdens de vooropleiding Algemene 
Heelkunde in het Camsius-Wilhelmina Ziekenhuis te Nijmegen 
(opleider Dr. H.J.M. Joosten), als voorbereiding op de ver-
dere opleiding tot uroloog. 
Ik wil op deze plaats iedereen danken die direkt en indirekt 
betrokken is geweest bij het tot stand komen van dit proef-
schrift. In het bijzonder dank ik de medewerkers van het 
"kweeklab" en de artsen en het personeel van de operatie-
kamer en de polikliniek van de afdeling Urologie, die immer 
bereid waren materiaal voor het onderzoek te verzamelen. 

CHAPTER 1. 
GENERAL INTRODUCTION. 
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INTRODUCTION: 
Most common tumors of the bladder are the epithelial type 
tumors. Histologically, the vast majority of the epithelial 
tumors are the transitional cell type tumors.(1) 
The histological classification separates transitional cell 
tumors from squamous, glandular and undifferentiated forms. 
(Table 1.) 
Transitional cell papilloma has a highly restrictive definition 
i.e. "a papillary tumor with a delicate fibrovascular stroma 
covered by regular transitional epithelium indistinguishable 
from that of the normal bladder and not more than six layers 
thick". There should be no evidence of anaplasia. Because of 
this high threshold the proportion of papillomas is very limited 
in most series; less than three percent of all epithelial tumors 
of the bladder. 
Transitional cell carcinoma is classified, considering histolo-
gical grade and growth pattern. In bladder cancer histological 
and cytological grading is of considerable clinical importance. 
The grading is based on anaplasia i.e. cellular abnormalities 
m size, shape, staining and mitotic activity. By the W.H.O. 
a classification is proposed in which three grades are employed. 
(2,3) 
Grade 1 applies to tumors that have the least degree of cellular 
anaplasia, compatible with the diagnosis of malignancy; Grade 3 
applies to tumors with the most severe degree of anaplasia; 
Grade 2 lies in between. The growth patters are described using 
four groups as follows: 
1) Papillary: the tumor is growing in the lumen of the bladder. 
2) Infiltrating: the tumor is growing in the wall of the bladder, 
3) Papillary and infiltrating: the tumor is doing both. 
4) Non-papillary and non-infiltrating: the tumor is confined to 
the surface. 
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Table 1. Histological classification of urinary bladder tumors (1) 
I. Epithelial tumors 
A. Transitional cell papilloma 
B. Transitional cell papilloma, 
inverted type 
C. Squamous cell papilloma 
D. Tranbitional cell carcinoma 
E. Variants of transitional cell 
carcinoma 
1. with squamous metaplasia 
2. with glandular metaplasia 
3. with squamous and glandular 
metaplasia 
F. Squamous cell carcinoma 
G. Adenocarcinoma 
H. Undifferentiated carcinoma 
II. Non-epithelial tumorb 
A. Benign 
B. Malignant 
1. Rhabdomyosarcoma 
2. Others 
V. Unclassified tumors 
VI. Epithelial abnormalities 
A. Papillary (polypoid) 
"cystitis" 
B. Von Brunn's nests 
С "Cystitis" cystica 
D. Glandular metaplasia 
E. "Nephrogenic adenoma" 
F. Squamous metaplasia 
VII.Tumor-like lesions 
A. Follicular cystitis 
B. Malakoplakia 
C. Amyloidosis 
D. Fibrous (f ιbroepithelial ) 
polyp 
E. Endometriosis 
F. Hamartomas 
G. Cysts 
III.Miscellaneous tumors 
A. Phaeochromocytoma 
B. Lymphomas 
C. Carcinosarcoma 
D. Malignant melanoma 
E. Others 
IV. Metastatic tumors and secondary 
ex tensions 
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Transitional cell carcinoma is not confined to the epithelium 
of the bladder. In the modern concept of the collecting system, 
the urinary tract is a single functional unit.(4) It is this 
concept of a total urothelial disease that explains the distri-
bution and behavior of many tumors.(5) In 1952 Melicow presented 
the results of a "Histological study of the vesical urothelium 
intervening between gross neoplasms in total cystectomy" (6) in 
which 10 bladder specimens were studied, all bearing gross 
invasive cancer. Apart from sections of the tumors, pieces of 
smooth, normal appearing bladder tissue were made. These sections 
showed foci of inflammation and urothelial hyperplasia and meta-
plasia, but also occasional localized areas of pronounced 
cellular atypism. These areas were labeled carcinoma in situ 
or intra-urothelial cancer. Carcinoma in situ was described as 
an equivalent of Bowen's disease, or intra-epithelial cancer of 
the epidermis. (7) It was stated that carcinoma in situ of the 
urothelium were all early focal cancers limited to their respec-
tive surface linings, but possesing a potential for invasiveness. 
Because of the multicentric character of the disease in a 
number of patients, an evaluation has to be made of the neoplastic 
potential of the tumor. For this purpose the urologist must 
obtain additional material. This material can be tissue samples 
taken from selected mucosal sites or cellular samples obtained 
from urine or bladder washings. (8) The mucosal biopsies from 
selected sites are preferably taken using a "cold" biopsy instru-
ment and should be submitted to the pathologist in a fixative 
in separate containers, each clearly marked by the site of 
origin. In the standard procedure used by the Clinical Collabo-
rative Group A of the National Bladder Cancer Project biopsies 
are taken of apparently normal mucosa adjacent to the tumor 
and three other biopsies of apparently normal mucosa, one lateral 
to each ureteral orifice and one from the upper posterior wall. 
(9) 
Besides the classification of the histological type and the 
grade of the tumor the clinical and histologic stage of the 
tumor have to be determined. 
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Table 2. Clinical versus microscopical staging. 
CLINICALLY: MICROSCOPICALLY: 
TO : no evidence of primary 
tumor . 
Tl : on bimanual examination no 
tumor or a freely mobile 
mass may be felt: this 
should not be felt after 
complete transurethral 
resection of the lesion. 
T2 : on bimanual examination 
there is induration of the 
bladder wall which is mobile; 
there is no residual indura­
tion after complete trans­
urethral resection. 
pTis: pre-invasive carcinoma, 
carcinoma in situ. 
pTA : papillary non-invasive 
care inoma. 
pTO : no evidence of tumor 
found on histological 
examination of the 
specimen . 
pTl : tumor not extending 
beyond the lamina 
propria. 
pT2 : tumor with invasion of 
superficial muscle (not 
more than halfway through 
muscle coat). 
T3 : on bimanual examination indu- рТЗ 
ration or a mobile nodular 
mass is palpable in the blad­
der wall which persists after 
transurethral resection of the 
exophytic portion of the 
lesion. 
T4 : tumor fixed or extending to pT4 
neighbouring structures: 
T4a: tumor infiltrating 
prostate, uterus or 
vagina. 
T4b: tumor fixed to pelvic 
wall and/or abdominal 
wall. 
tumor with invasion of 
deep muscle (more than 
halfway through muscle 
coat) T3a; or with inva­
sion of perivesical 
tissue , T3b. 
tumor with invasion of 
prostate or other extra-
vesical structures. 
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Clinically the tumor is staged according to the Τ. Ν .M. -сіазы-
fication (U . I.С.С . ) .(10) There are differences between the 
clinical classification and the histopathological classification. 
(Table 2) 
The N-classification is used to describe involvement of regio­
nal (N0-N3) and juxta-regional lymphodes (N4). 
The M-classification describes the presence of distant metas­
tases; MO, no evidence of distant metastases and Ml, positive 
evidence of distant metastases. 
Microscopically it is not possible for the pathologist to 
differentiate between pT2 and рТЗа on endoresection specimens. 
For this differentiation a cystectomy specimen is needed to 
evaluate depth of infiltration in the muscle coat of the blad­
der . 
For prognosis the lamina propria is an important border. The 
recurrence rate is higher after transurethral resection in Tl 
tumors than in TO tumors.(11) 
Other prognostic factors for likelihood of recurrence were 
multiplicity, size equal to or greater than 3 cm and abnormal 
selected mucosal biopsies. 
Positive urinary cytology and higher grade correlated with 
prognosis though less strongly.(11) According to the study 
of the EORTC Gemto-Urinary Tract Cancer Cooperative Group 
the number of tumors at presentation is the most important 
prognostic factor followed by, in order of importance, the 
recurrence rate at entry of the study and size of the largest 
tumor.(12) However Loening et al (13) found no predictive value 
for tumor recurrence of initial grade, stage, number and size 
of bladder tumors. None of the observed parameters alone or in 
combination could predict tumor recurrence. 
The recurrence rate of urothelial tumors is high, 50-80%.(1A,15) 
A fourth of the tumors will recur as higher grade lesions (15) 
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and depending on the histologic grade of the original tumor 
8 to 57% of the patients will have subsequent invasive tumors. 
(16) This suggests a progression with the time from low-grade 
low-stage tumors to high-grade infiltrating tumors. This ob­
servation could not be confirmed by Kaye and Lange (17), who 
found that of 166 patients with invasive bladder cancer only 
16% had prior non-invasive bladder tumors. They reported that 
death from bladder cancer occurs primarily among patients who 
have never had a recognized, early bladder tumor. 
According to grade and most important stage of the bladder 
cancer, different treatment modalities are applied. 
Superficial bladder tumors are treated with transurethral 
electroresection or fulgeration.This therapy is based on expe­
riments with animal model systems (carcinoma-induced tumors 
in syngeneic mice) (18) and prospective randomised clinical 
studies as performed by the EORTC Genito-Urтагу Tract Cancer 
Cooperative Group comparing agents as Thiotepa, Epipodophyllo-
toxin (VM 26) and TUR alone.(19) Thiotepa significantly reduced 
the recurrence rate as compared with the control group or 
VM 26. Intravesically administered doxorubicin (Adriamycin) 
showed effect on the recurrence rate after TUR.(20) Also the 
effects on the recurrence rate were studied using high dose 
oral Bacillus Calmette-Guerin (BCG) (21) showing effect on the 
recurrence rate. Also the combination intravenous cyclophospha­
mide plus orally or intravesically administered BCG was repor­
ted to have an effect on the recurrence rate.(22) In animal 
tumor model systems these effects of BCG on superficial bladder 
tumors could be confirmed.(23 , 2A) 
Also the effect of intravesical administered BCG was evaluated 
on CIS of the bladder. Fifty-five percent of the patients 
treated with BCG obtained complete regression for a median du­
ration of 18 months as determined by negative urine cytology 
and negative bladder biopsies.(25) Some effect of Adriamycin 
intravesically was showed against CIS (26) and against super­
ficial bladder tumors without prior resection.(27) 
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Intravesically administered Cisplatin showed little effect on 
CIS and pTl tumors.(28) Also intravenous Cisplatin induced no 
complete remissions of superficial bladder tumors.(29) The 
current treatment of superficial transitional cell carcinoma 
of the bladder consists of transurethral resection of the 
exophytic tumor. It is advisable to take separate biopsies of 
the bottom of the resected area. Furthermore random cold cup 
biopsies are taken from the normal appearing bladder mucosa 
at selected sites. After resection, intravesically chemothera-
peutic drugs (Adriamycin, Thiotepa) are administered for seve-
ral months. Radiotherapy for low-stage bladder cancer is not 
the optimal treatment for these patients.(30) 
At the moment follow-up measures consist of repeated cystoscopy 
and urine cytology. The patients who had a TA-T1 transitional 
cell carcinoma, accompanied by CIS or patients with CIS alone 
need very careful follow-up. As soon as progression occurs to 
infiltrating tumor more definite measures are needed. 
Treatment for infiltrating bladder tumors (T2,T3) without 
metastases is in discussion. Radiation therapy is still con-
troversial as a treatment for bladder cancer given pre-opera-
tively and as radical treatment.(31,32) For highly selected 
cases (small, solitary tumors with limited infiltration) in-
terstitial irradiation is proposed as an effective measure. 
(33,34) In the treatment of T3NXN0 carcinoma of the bladder 
the combination of radium inplant and external irradiation 
was proposed for tumors smaller than 5 cm.(35) The results 
were excellent in low grade tumors without vascular invasion, 
prognosis was poor if a high grade tumor with vascular inva-
sion was treated. Most common practice for deeply infiltrating 
bladder tumors is the combination of pre-operative radiation 
followed by radical cystectomy.(36,37,38,39) Radiation doses 
varied from 2000-6000 rad. Early death of the patients was 
related to the post-operative complications due to the combined 
approach. Later deaths were due to tumor recurrences and late 
complications. 
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Several adjuvant chemotherapy protocols have been reported (40, 
Al,42) because of the high probability of subclinical metasta-
tic disease in patients with deeply infiltrating bladder tumors. 
The results are still questionable because no highly effective 
drug has been identified against transitional cell carcinoma. 
To improve survival of patients with metastasized transitional 
cell carcinoma many cytotoxic drugs, single and in combination 
have been evaluated. Much attention was given to Methotrexate 
(43,44), Adriamycin (45), Bleomycin (46) and most recently 
Cis-Diamine-Dichloride Platinum II (47) as single agents. Many 
drug combination regimens were evaluated. (48,49,50) Reviews 
on systemic chemotherapy used against metastasized transitional 
cell carcinoma are given by Carter (51,52), Pavone-Macaluso 
(53), DeKernion (54), Bush (55), Smith (56), Baumgartner (57) 
and Paulson (58). It can be concluded that no highly effective 
drug or drug combination exists against transitional cell carci-
noma. Effectivity of CDDP (cisplatin) is most consistent as is 
expressed by response rates between 33-57% in several studies. 
(58) It is questionable if the higher toxicity of combination 
drug regimens is in balance with better results. The overall du-
ration of remissions is in the range of 5-6 months practically 
unrelated to the drug regimen used.(58) 
At the time the present study was started (1981), patients with 
metastasized transitional cell carcinoma were treated with the 
combination: cisplatinum, adriamycin and 5-fluorouracil.(59) 
Because of the moderate effect this combination seemed to have 
on transitional cell carcinoma and the serious side effects ac-
companying this drug combination, need was felt for an in vitro 
test for sensitivity testing of tumors against cytotoxic drugs. 
At that time first reports became available about the Hamburger 
and Salmon double layer soft agar method.(60,61,62,63,64,65) 
Favorable results were presented about correlations between in 
vitro and in vivo drug sensitivity and resistance of a variety 
of solid tumors.(62,63,65,66) 
From fresh unfixed tumor material single cell suspensions are 
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prepared mechanically (crossed scalpels or scissors) eventually 
followed by enzymatic disaggregation (67) using 0.8% collagenase 
type II and 0.002% DNase. After washing the cells and disposal 
of cell clumps in the suspension (by means of filtering and 
aspirating the cell suspension through fine needles) the cells 
are counted in a hemocytometer and viability is determined with 
a dye exclusion test (Trypan blue). 
The cell suspension is diluted to 3x10 cells per ml. For drug 
sensitivity testing 0.5 ml aliquots of the cell suspension are 
exposed to the various drugs to be tested. Drug concentrations 
are 10% of the peak plasma concentration in vivo achievable. 
Exposure to the drug lasts one hour. After washing the cells, 
the cells are plated in triplicate in a 0.3% agar layer of 
double enriched CMRL1066 over a bottom layer of 0.5% agar in 
double enriched McCoy's 5A medium in 35 mm petri dishes. The 
originally described conditioned medium was omitted in the 
present study. In an incubator at 37CC and 6% C0 9 in the 
atmosphere tumor cell colonies were allowed to develop from the 
presumed stem cells present in the cultures. The colonies formed 
are counted. The difference between the control cultures (not 
drug рге-treated cells) and the drug рге-treated cells in culture 
indicates drug sensitivity or resistance. A minimum of 30 
colonies in the control dishes were demanded to accept a culture 
as évaluable; for sensitivity 70% inhibition of colony growth 
was needed.(66) Colony counting is performed using an inverted 
microscope or an automated colony counter, Omnicon Feature 
Analysis System II (Bausch and Lomb, Rochester NY,USA).(68) 
This culturing system was not yet systematically used on 
transitional cell carcinoma. Some reports were available based 
on limited numbers of tumors (69,70) which gave us an opportunity 
to investigate the possibilities of this system to test cytotoxic 
drugs on transitional cell carcinoma. It would be possible to 
compare our results with other laboratories with a similar 
experience with other solid tumors. 
As described by Hamburger (71) an ideal in vitro test should 
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be simple, statistically acceptable, easily standardized, 
cheap, rapid, flexible and capable of taking into account various 
methods of drug action and should offer reasonable correlations 
with in vivo effects. The double layer soft agar culturing system 
is based upon the theoretical existence of stem cells in a tumor 
as was first described by McCulloch and Till in 1961.(71) These 
stem cells are held responsible for the cell renewal in a tumor, 
the growth of a tumor, and eventually for outgrowth of tumors at 
distant localisations c.q. metastases. Less than 1% of the total 
number of cells are believed to have stem cell properties. In the 
double layer soft agar culturing system the stem cells, better 
called clonogenic cells, of malignant tumors will form colonies 
with time (3-4 weeks). These colonies can be counted. The first 
question to be answered by the present study was whether it is 
possible to culture transitional cell carcinoma in a routine 
set up, and eventually to test cytotoxic drugs with this system 
comparing the results with those reported for other solid tumors 
in the first retrospective studies published. 
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ABSTRACT: 
Soft agar culture of transitional cell carcinoma colonies from 
urine, bladder irrigation fluid, and transurethral resection 
solid tumor specimens demonstrate generally better growth of 
tumor cell colonies from urine than from irrigation fluid. 
Growth of tumor colonies from urine was adequate to evaluate 
presence of tumor and to study growth parameters of the tumor 
colonies in vitro, although the number of colonies produced 
from urine was inadequate to evaluate sensitivity or resis-
tance to chemotherapeutic agents. Growth in soft agar of 
transitional cell carcinoma colonies from urine may offer a 
simple, noninvasive method of evaluating the effectiveness 
of therapy and the prognosis for tumor progression. 
(Key words: Tumor stem cells; Soft agar culture; Clonogenic 
cell culture; Transitional cell carcinoma; Bladder cancer) 
Am J Clin Pathol 1982; 78: 690-694. 
INTRODUCTION: 
Since the report of Hamburger and Salmon (3) describing the 
culture technics of tumor "stem" cell colonies from humans in 
a double layer soft-agar system, this cloning system (HTCS) 
of tumors from humans has become a popular investigational 
tool to determine resistance or sensitivity of individual 
patients' tumors to chemotherapeutic agents in vitro (2,9,10) 
Preliminary data suggest that this method may prove very help 
ful in predicting patients' response in vivo to chemotherapy 
regimens (2 ) . 
In addition to determining chemotherapy sensitivity and resis 
tance at least two other potential applications of this tumor 
cell culture method have been suggested (Herman and colleague 
Arch Pathol Lab Med, in press). Growth of tumor colonies in 
soft agar may provide a means of assessing the effectiveness 
of chemo- or radiation therapy by determining the presence of 
"viable", i.e., clonogenic, tumor cells in post-therapy biops 
specimens. In addition, the parameters of growth in soft agar 
may be a predictor of tumor behavior, i.e., prognosis, espe-
cially in those tumors, such as ovarian epithelial and papil-
lary transitional cell, where the borderline between "benign" 
and malignant is not sharply discernible by routine pathologi 
examination . 
Further investigation and potential routine clinical applica-
tion of the cloning system of tumors from humans in these and 
other problems in clinical oncology will be facilitated consi 
derably by the development of technics for obtaining quality 
tumor cells for culture with minimal trauma to the patient. S 
far, most reports dealing with culture of tumors from humans 
have used tumor biopsies as a source of tumor cells. Increasi 
use has been reported of effusions and irrigation fluids (1,6 
11). The present work reports the culture of transitional eel 
colonies from urine specimens of humans and compares the 
results of culture of bladder biopsy and irrigation specimens 
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MATERIALS AND METHODS: 
Twenty patients admitted to the Radboud Hospital for transure-
thral resection of a transitional cell bladder tumor (newly 
diagnosed or recurrent) formed the population of the present 
series. From these 20 patients, 18 solid tumors, 12 urine 
samples and 12 bladder irrigation fluid samples were obtained 
for HTCS. The urine was collected in a sterile urine bag before 
the resection was started, through the cystoscope sheath. After 
the urine collection the bladder was filled with 50-100 ml 5% 
glucose in water. Then the bladder was gently lavaged with a 
Thoomy syringe. This irrigation fluid was also collected in a 
sterile urine bag. 
Following urine and irrigation fluid collection, the transure-
thral resection was started. Approximately 1-2 gr tissue was 
taken for HTCS after ensuring that adequate, representative 
material was taken for routine histopathologic study. For HTCS 
the exophytic portion of the tumor was taken in most cases. 
After collection, the urine and irrigation fluid were brought 
to the pathology laboratory and transferred to sterile 50 ml 
centrifuge tubes. The samples were spun for 10 min at 1,500 
rpm, the supernatant discarded, and 10-20 ml McCoy's wash was 
added to the cell pellet. After thorough vortexing, the cell 
suspensions were combined into one tube, urine and irrigation 
fluid separately. After another washing of the cells, McCoy's 
wash was added to the cell pellet, 2-5 ml according to the 
estimated number of cells obtained and the specimens were pro-
cessed further as described below for the cell suspensions ob-
tained from solid tumor. 
The solid tumor was brought to the pathology laboratory in 
sterile 0.9% NaCl solution and further processed as recently 
described in detail (9). In brief, the tissue was minced with 
scissors for 10 min in McCoy's wash through a metal sieve with 
60 holes per inch. The suspension of cells was then syringed 
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once manually through a 25 g 1 in needle and washed twice in 
McCoy's wash. Try pan-blue-excluding cells were determined using 
0.1 ml cell suspension and 0.1 ml trypan blue. The cell concen-
tration was determined in a Burker-Turk hemocytometer. The con-
centration of large nucleated cells was then adjusted to 3x10 
cells per ml McCoy's wash. Culture dishes (35mm) were seeded 
with 5x10 large nucleated cells per dish in double layer soft 
agar exactly as described elsewhere (3,10), except that condi-
tioned medium was not used. Culture dishes were examined within 
24 hours after plating to evaluate presence of clumps seeded 
into culture and rule out infection of the culture. Colonies 
of tumor cells were first examined after one week after pla-
ting. 
Part of the cell suspension not used for plating was air-dried 
and stained by the Papanicolaou technic to assess cell morpho-
logy and the types of cells brought into culture. Detailed 
morphologic studies of the colonies and other structures were 
performed on agar layers mounted on standard glass slides (8) 
and stained with the Periodic Acid Schiff reaction. From selec-
ted cultures, parrafin sections were made of colonies, stained 
with hematoxylin and eosin (7), and the tumor histology in the 
original biopsy specimens. 
RESULTS: 
Table 1 summarizes the patient and culture data in the present 
series. Of the total 42 samples cultured, 25 showed growth in 
the soft-agar system, growth being defined as five or more co-
lonies composed of 30 or more tumor cells per plate. An addi-
tional 7 cultures could not be evaluated because of bacterial 
or fungal infection of the cultures or a markedly bloody back-
ground. Of the 12 urines cultured, 8 showed growth, which com-
pares favorably with the 12 of 18 tumor samples which showed 
growth and is notably better than the 5 of 12 specimens from 
irrigation fluid which showed évaluable growth. 
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Table 1 Human Transitional Cell Carcinomas Cultured in HTCS Clinical 
and Pathologic Data and Culture Results 
Patient 
Number 
' 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
Age/Sex 
Comments 
31/m 
TUR 
Cystectomy (after 2000 rad 
radiation) 
68/m 
recurrence 
65/m 
53/m 
70/m 
recurrence 
70/f 
56/m 
recurrence (after 
adnamycin therapy) 
69/m 
64/m 
76/m 
53/m 
same patient as number 4. 
74/f 
62/f 
76/m 
48/Г 
46/m 
47/m 
65/f 
76/Г 
70/m 
35/m 
Grade 
11-111 
0 
I M t l 
I I I 
l l- l l l 
l-ll 
l-ll 
1 
II 
11-111 
III 
completion of 
ІІ-Ш 
l-ll 
II 
l-II 
1 
II 
l l- l l l 
1 
II 
I I 
Recurrence during adnamycin therapy 
Pathologic 
Stage 
Tlb-T2N0M0 
TO 
Τ2ΝΧΜ+·> 
pT2 
T 1 N X M 0 
T A N X M 0 
TA-T1NXM0 
T A N X M 0 
T 1 N X M 0 
T2NXM0 
pT2 
resection 
pTl 
TANXMO 
T I - T 2 N X M 0 
TANXMO 
TANXMO 
T I - T 2 N X M 0 
T 3 N X M f 
T I N X M O 
T2NXM0 
T2NXM0 
Culture Plates' 
Unne 
Irrigation fluid 
Tumor 
Tumor 
Unne 
Imgation fluid 
Unne 
Imgation Fluid 
Tumor 
Unne 
Imgation fluid 
Tumor 
Unne 
Imgation fluid 
Unne 
Imgation fluid 
Tumor 
Unne 
Imgation fluid 
Unne 
Imgation fluid 
Unne 
Imgation fluid 
Tumor 
Unne 
Imgation fluid 
Tumor 
Unne 
Imgation fluid 
Tumor 
Unne 
Imgation fluid 
Tumor 
Unne 
Irrigation fluid 
Tumor 
Tumor 
Tumor 
Tumor 
Tumor 
lumor 
Tumor 
Tumor 
Tumor 
1/1 
17/3 
137/6 
4/3 
less than 1/0 
3/3 
15/6 
0 
78/6 
15/6 
10/6 
78/6 
1/1 
5/3 
9/5 
43/4 
12/6 
l/l 
5/3 
1/1 
1/1 
1/1 
2/2 
1/1 
6/6 
8/6 
124/6 
36/3 
94/3 
149/3 
32/6 
23/6 
153/3 
6/6 
6/3 
27/6 
72/3 
3/3 
206/9 
184/9 
34/9 
134/9 
33/3 
59/3 
Colony Count per 
Plate Mean (Rangelt 
Infection 
Infection 
85(75-95) 
No growth 
2 ' 
Growth posmvet 
Growth posmvet 
28 (23-40) 
9(6-13) 
77(61-105) 
Growth posmvet 
10(4-16) 
19(13-29) 
Growth negative 
26(12-45) 
Growth negative 
Growth negative 
Not counted bloody 
background 
Not counted bloody 
background 
24 
4 (0-8) 
1 
25(13-33) 
More than 100 
More than 100 
32 (30-34) 
1 (0-3) 
5 (2-6) 
15(6-24) 
52(11-104) 
17(15-20) 
Infection 
Infection 
70 (52-93) 
75(71-78) 
2 ' 
Growth negative 
17(5-39) 
77 (50-89) 
Growth negative 
10(9-12) 
Infection 
* S x IO3 large nuclcalcd celli per culluir plaie Number of possible c u l l u m from the 
specimen/Number of culture diihci aciually « ι up 
t Mean and range о Г п з І о т counis 
% Growth ckari) recogmiahk coloni« could noi he counted because of bacienal or fungal 
infecí inn 
3 3 
щф 
Vf 
Fig. 1 (left). Nest of transitional cell carcinoma (Grade II, Stage pTl) in 
bladder lamina propria of 52-year old man. Hematoxylin and eosin, (x40). 
Fig. 2 (right). Colony of transitional cell carcinoma from the same tumor il­
lustrated in Figure 1 after 2.5 weeks of growth in soft-agar culture. 
The cytologic and "histologic" features of the colony reproduce those 
of the tumor cell nest in the biopsy material of Figure 1. PAS (x40). 
45MCfá 
* \ 
Fig. 3. 4u section of paraffin-embed-
ded colony of transitional 
cell carcinoma, similar to 
the intact colony shown in 
Figure 2. Hematoxylin and 
eosin, (x50). 
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Table 2 Correlation of Tumor Grade with Number of 
Colonies Produced in Soft Agar (Mean, Range) 
Grade Unne Irrigation Fluid 
2 Π 
I-II 
II 
II-III 
III 
19(13-29) 
Growth negative 
t 
24 
t 
X 
% 
25(13-33) 
15(6-24) 
28 (23-tO) 
32 (30-40) 
Growth negative 
Growth negative 
t 
4(8-0) 
t 
10(4-16) 
>ioo 
52(1-104) 
9(6-13) 
1 (0-3) 
Growth negative 
Growth negative 
26(12^*5) 
70 (52-93) 
2 C) 
1 
75(71-78) 
17 (5-39) 
10(9-12) 
t 
85 (75-95) 
Growth negative§ 
X 
>I00 
17(15-20) 
77(50-89) 
77(61-105) 
5 (2-6) 
• Not counted because of markedly bloody background in culture 
t Noi évaluable because of hactenal or fungal ιηΓεηιοπ in culture 
% More than five tumor cell colonies clearly recognizable but reliable counting was not 
possible because of bacterial or fungal infection 
§ No growih after 2 000 rad radiation to the bladder (same patient as the first line of the 
11-111 group) 
Table 3 Correlation of Tumor Stage with Number of 
Colonies Produced in Soft Agar (Mean, Range) 
Stage 
pTO 
pTA 
pTA-TI 
pTl 
pTl-T2 
pT2 
Unnc 
19(13-29) 
• t 
Growth negative 
X 
24 
15(6-24) 
Growth negative 
t 
X 
28 (23-40) 
25(13-33) 
32 (30-34) 
Imgation Fluid 
2 0 
Growth negative 
* t 
Growth negative 
10(4-16) 
4 (0-8) 
52(11-104) 
t 
9(6-13) 
>100 
I (0-3) 
Tumor 
26(12-45) 
70 (52-93) 
2 f) 
Growth negative 
17(15-20) 
85 (75-95) 
§ 
75(71-78) 
17 (5-39) 
t 
t 
77(61-105) 
>100 
5 (2-6) 
10(9-12) 
t 
77 (50-89) 
* Not counted because of markedly bloody background in culture 
t Not évaluable because of bacterial or fungal infetdon ш culture 
t More than use tumor cell colonies clearlv recognizable but reliable counting was not 
possible because of bacterial or fungal infection 
§ No growth after 2 000 rad radiation to the bladder (same patient as the first line of the 
p T l - T 2 group) 
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At least one culture plate from each sample was evaluated after 
termination of the culture by examination of a PAS-stained agar 
layer containing colonies. In all cases the morphologic features 
of the cells comprising the tumor colonies in agar were clearly 
recognizable as being those of transitional cell carcinoma. In 
most but not all cases, the histo- and cytopathologic grading 
of the tumor as grown in agar agreed with the grade of tumor as 
seen in the histologic material. Figure 1 shows an invasive 
transitional cell carcinoma in hematoxylin-and-eosin-stained, 
parrafin block material. Figure 2 is a colony of tumor cells 
from the same tumor after 2.5 weeks in agar culture. Figure 3 
is a hematoxylin-and-eosin-stained, parrafin section of a co-
lony similar to that shown in Figure 2. The cytologic and his-
tologic features of the cell nests are comparable. 
Table 2 shows the correlation of colony growth in agar with 
histopathologic grading of the tumor. Table 3 shows the corre-
lation of colony growth with tumor stage (pT) according to the 
UICC criteria (4). These data demonstrate that, in general, 
more colonies are produced in agar from tumor samples than 
from either urine or irrigation fluid. However, in general, 
urine seems to produce évaluable growth more reliably than 
irrigation fluid. Although the number of samples tested is 
small, the number of colonies per culture plate produced from 
urine samples shows a trend toward correlation with grade and 
stage of tumor, a trend not identifiable in cultures of irri-
gation fluid or solid tumor specimens. 
DISCUSSION: 
The present data demonstrate that évaluable growth of human 
transitional cell carcinoma colonies in double-layer soft-agar 
culture can be obtained from urine samples. The number of co-
lonies per sample and the percentage of samples producing co-
lonies compares favorably with soft-agar culture of bladder 
irrigation fluid, though these parameters of growth are infe-
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гіог to culture of a solid tumor obtained by transurethral re­
section. The number of colonies produced from urine samples in 
soft-agar culture tends to correlate with the pathologic grade 
and stage of tumor. 
The evaluation of sensitivity or resistance of tumors to chemo-
therapeutic agents in vitro is the most technically demanding 
application of the cloning system of tumors from humans. In 
addition to demanding low between-plste variability of number 
of colonies and low infection rates, this application requires 
growth of at least 30-40 colonies per control (non-drug-incu­
bated) culture plate to reproducibly recognize significant 
tumor sensitivity to a chemo therapeutic agent in vitro. For 
this application of HTCS, the use of urine samples as reported 
here is still inadequate. 
However a second application of tumor cell culture, assessing 
the effectiveness of therapy by determining the presence of 
"viable" or clonogenic tumor cells after therapy is clearly 
feasible using urine samples. A positive soft-agar culture fol­
lowing therapy of a transitional cell carcinoma clearly indi­
cates that tumor cells with demonstrable proliferative capacity 
remain. How this information can be used to improve clinical 
management of patients with transitional cell carcinoma must 
be explored further by parallel and prospective clinical trials. 
The interpretation of a negative post-therapy soft-agar culture 
is made difficult by the relatively low growth rates of tumors 
in soft agar (9). Further improvement of the technics of HTCS 
may provide a partial solution to this problem. In addition, 
the fact that collection of urine samples is non-invasive makes 
frequent culturing possible and may in part negate some of the 
problems of low growth rate in culture (comparable to blood 
cultures in SBE). 
The third application of soft-agar culture of transitional cell 
carcinoma, evaluation of prognosis, clearly deserves further 
attention. The present data suggest a correlation of number of 
colonies produced in culture with the pathologic grade and 
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stage of tumor. If in fact further data support this correla-
tion, the culturing of repeated urine samples over time may 
provide a relatively easy, non-invasive technic for monitoring 
patients, especially those with low-grade papillary transitio-
nal cell tumors, for signs of progression, especially early in-
vasion. For this purpose, the availability of an automated co-
lony counter (5) offers the potential of amore sophisticated 
evaluation of tumor colony growth in culture. The availability, 
from the automated counter, of other parameters of colony 
growth, such as size distribution of colonies, rate of change 
of colony size distribution with time, and early rate of colo-
ny development, will provide objective quantitative measures 
of biologic behavior of tumors in vitro. These measures should 
provide a basis for comparison of in vitro growth with in vivo 
behavior that is both more varied and more reliable than manual 
observation and counting (5). 
The present study shows that the HTCS technic is easily imple-
mented in, and integrated into, the routine work flow of a 
pathology department, requiring little more in personnel and 
space than a very modest microbiology laboratory. The develop-
ment of non-invasive technics for obtaining tumor samples , as 
well as the routine soft-agar culturing of tumor samples ob-
tained for other purposes, will allow this method to be evalua-
ted further for potential contributions to solving a variety 
of patient management problems in clinical oncology. 
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ABSTRACT: 
Soft agar cultures of transitional cell carcinoma from urine, 
irrigation fluid and transurethral resection solid tumor speci-
mens show good colony growth. Growth of tumor colonies produced 
from urine was adequate to evaluate the presence of a viable 
tumor, since 12 of 18 noninfected cultures showed growth. The 
number of colonies produced was adequate to evaluate the sen-
sitivity or resistance to chemotherapy agents in only 3 of 18 
cultures. For irrigation fluid, similar results were obtained: 
9 of 17 noninfected cultures showed growth, while only 3 of 17 
were adequate for drug-sensitivity evaluation. For the evalua-
tion of sensitivity or resistance, tumor cell suspensions were 
most appropriate, 7 of 25 noninfected cultures showed 30 or 
more colonies/dish, whereas 17 of 25 showed growth. With the 
possibility of obtaining growth of tumor cells derived from 
urine, a prospective study is proposed to define the value of 
repeated urine cultures in monitoring the status of the uro-
thelium of patients treated for transitional cell carcinoma. 
Key words: Tumor cells - Stem cells - Soft agar culture -
Transitional cell carcinoma - Bladder cancer. 
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INTRODUCTION: 
Noninvasive papillary transitional cell carcinoma is often mul-
tifocal and has a recurrence rate after surgical excision of 
40-70% (Soloway, 1980). Approximately 10% of these tumors recur 
with an increase in grade and/or stage (Gilbert et al., 1978). 
Chemotherapy of the noninvasive tumors attempts to prolong the 
recurrence-free interval after transurethral resection (TUR). 
A variety of agents have been tried as intravesical therapy 
(e.g. adriamycin, mitomycin C, epodyl, thiotepa, cisplatin, 
VM 26). For advanced disease a truly effective chemotherapeutic 
regimen has not yet been developed. Cisplatin, as a single 
agent or in combination, is under investigation as are other 
drugs and combinations (Merrin et al., 1975; Cross et al.,1976; 
Yagoda et al., 1977, 1978; Turneretal., 1979). These regimens 
are not without risks and toxic side effects are usually dose-
limiting . 
To prevent morbidity induced by ineffective treatment, many 
techniques have been investigated to develop a predictive la-
boratory method to determine individual tumor sensitivity to 
the proposed drugs. Much attention has been given to the human 
tumor clonogenic cell culture, HTC3, developed by Hamburger 
and Salmon (1977). This cloning system, in which the human 
tumor clonogenic or "stem" cells produce colonies in a two-
layer soft agar system, has become a popular investigational 
tool to determine the resistance or sensitivity of individual 
patients' tumors to chemotherapeutic agents in vitro. Retro-
spective studies indicate that, in the tumor types investiga-
ted, this method predicts tumor sensitivity in vivo with 60-
70% accuracy (Hamburger, 1981). 
In addition to determining chemotherapy sensitivity and resis-
tance, at least two other potential applications of the tumor 
cell culture system have been suggested (Herman et al., 1983a, 
b; Kirkels et al., 1982). Growth of tumor cell colonies in 
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soft agar may provide a means of monitoring the effectiveness 
of all forms of therapy by determining the presence of clono-
genic and thus viable cells in post-therapy biopsies. Further­
more, in vitro growth parameters may provide a predictive means 
of determining tumor behavior, especially in those tumors where 
the borderline between benign and malignant is not sharply dis­
cernible by routine pathologic examination; e.g. papillary 
transitional cell carcinoma. 
For further investigation of these and other questions, it is 
very important to obtain good quality tumor cells for culture 
with a minimum of trauma to the patient. Most published reports 
deal with cultures of tumor biopsies and more recently of ef­
fusions and irrigation fluids (Buick et al., 1979; Stanisic 
and Buick, 1980; Niell et al., 1982). The present paper reports 
the culture of human transitional cell carcinoma colonies from 
urine, as well ач tumor biopsies and bladder irrigation fluid, 
and compares the results of tumor cell culture from these three 
specimen sources. 
MATERIALS AND METHODS: 
From patients admitted to the Urology Department of Radboud 
Hospital for TUR of a transitional cell bladder tumor (newly 
diagnosed or recurrent), 32 tumor samples, 29 urine samples 
and 29 bladder irrigation fluid samples were obtained for 
НТСЬЗ. 
The urine, collected before resection, was obtained m a ste­
rile urine bag through the cystoscope sheath. After the urine 
collection, 50-100 ml 5% glucose in water was instilled into 
the bladder. Then the bladder was lavaged with a Thoomy syrin­
ge. This irrigation fluid was also collected in a sterile 
urine bag. After fluid collection, tumor resection was started. 
Approximately 3-5 g tumor tissue was taken for HTC3 after en­
suring that adequate representative material was submitted for 
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routine histologic examination. In most cases the exophytic 
part of the tumor was taken for HTC3 
After collection,all samples were transported to the pathology 
laboratory where the urine and irrigation fluid were transfer­
red to sterile 50 ml centrifuge tubes. The cells were centri-
fuged twice (400 g for 10 min), resuspended in 2-5 ml McCoy's 
wash according to the estimated number of cells obtained, and 
processed further as described below for the cell suspensions 
obtained from solid tumor. 
Ihe solid tumor was brought to the laboratory in sterile 0.9 
NaCl solution and further processed as described elsewhere in 
detail (Salmon, 1980). 
In brief, the tumor tissue is minced with scissors for 10 m m 
in McCoy's wash through a sterile metal sieve. The resultant 
cell suspension and the pieces of tumor remaining in the sieve 
are incubated with collagenase and DNase for 2 h at 37° С in 
a 6% CO» atmosphere (Slocum et al., 1981), oyringed once manu­
ally through a 25-gauge needle and washed twice with McCoy's 
wash. Trypan-blue-cxcluding cells are determined using 0.1 ml 
of the cell suspension, and the number of large nucleated cells 
is determined in a Burker Turk hemocytomeLer . The cell concen­
tration is tl 
McCoy's wash. 
hen adjusted to 3x10 large nucleated cells/ml 
35-mm culture dishes are seeded with 5x10 large nucleated 
cells per dish in double-enriched CMRL 1066 with 0.3% agar on 
a bottom layer of 0.5% agar exactly as described by Salmon et 
al. (1978), except that conditioned medium is not used. Culture 
dishes are examined within 24 h after plating to rule out in­
fection of the culture and to evaluate the presence of clumps 
seeded into culture. 
Since the patients did not receive antibiotics as routine, we 
tried to suppress possible infection with a double amount of 
penicillin/streptomycin added to the McCoy's wash during prepara-
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Fig. 1. Transitional cell carcinoma grade II-III In a bladder 
tumor biopsy. HE. x50. 
Fig. 2. Thin section of a paraffin-block colony of transitional 
cell carcinoma grown from a urine sample of the same pa­
tient illustrated in figure 1, after 3 weeks in soft-
agar culture. The "histologic" and cytologic features 
of the colony reproduce those of the tumor cell nest 
in the biopsy material of figure 1. PAS. x50. 
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tion of the single cell suspension, with no improvement of the 
results. To prevent introduction of an air-borne infection in 
the incubator during incubation, we put the individual culture 
dishes in a larger (90 mm) Petri dish with good results. In the 
cultures described in this report, the number of infected cul-
tures is significantly lowered. 
Colonies of tumor cells are examined with an inverted micro-
scope beginning after 1 week in culture. A colony of tumor 
cells is defined as a three-dimensional cellular aggregate 
with smooth borders containing 30 or more cells (Herman et al., 
1983a, b). 
Part of the cell suspension used to prepare the culture is air 
dried on a standard glass microscope slide and Papanicolaou 
stained to assess cell morphology and the types of cells 
brought into culture. 
Detailed morphologic studies of the colonies and other struc-
tures in culture are performed on agar layers mounted on stan-
dard glass slides (Salmon, 1979) and stained with the periodic 
acid-Schiff reaction. From selected cultures, formalin-fixed 
paraffin blocks are made and 4- to 6-um sections are prepared, 
similar to routine histologic preparations (Pavelic et al., 
1981) and stained with hematoxylin and eosin. The tumor colo-
ny morphology is compared with the tumor histology and/or cy-
tology in the original biopsy specimens. 
RESULTS: 
In table I a summary is given of the numbers of cultures perfor-
med from the different sources of tumor cells. Only the results 
from cultures performed on urine, irrigation fluids and tumor 
samples obtained from patients with histologically proven tran-
sitional cell carcinoma are included. From an initial 90 cultu-
res, 60 were évaluable. The remaining 30 cultures were not 
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évaluable due to fungal and/or bacterial infections, 
TABLE T.SOURCES OF TUMOR CELLS AND GROWTH IN CULTURE. 
Number Infected Number Number of growth 
of of positive cultures 
cultures évaluable 
cultures > 5 > 30 
colonies/ colonies/ 
dish dish 
Urine 29 11 18 12 
Irrigation 
fluid 29 12 17 
Tumor cell 
suspension 32 25 17 
Table I also shows the number of cultures with 5 or more colo-
nies and 30 or more colonies/culture plate. 5 Colonies/culture 
plate is accepted as an arbitrary number of colonies in a cul-
ture to conclude that it is growth positive. 38 of 60 cultures 
showed 5 or more colonies/culture plate. 30 or more colonies/ 
culture plate are needed for in vitro drug testing. For eva-
luation of drug sensitivity or resistance, tumor cell suspen-
sion cultures can best be used, since 7 of 25 cell suspension 
cultures showed a mean of 30 or more colonies/culture plate. 
For evaluation of growth potential, urine and tumor cell sus-
pensions are equally useful as a source of tumor cells. 12 of 
19 urine cultures showed positive growth, compared with 17 of 
25 tumor cell cultures. Cultures of irrigation fluid showed 
slightly worse results: 9 of 17 cultures were growth positive. 
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TABLE II. CORRELATION OF TUMOR GRADE AND MEAN NUMBER OF 
COLONIES PRODUCED IN SOFT AGAR. 
Tumor grade 
I 
I-II 
II 
II-III 
III 
The ranges are 
Urine 
-
_ 
24 
0 
14 
-
5 
22 
-
5 
-
-
-
-
25 
32 
3 
-
-
25 
-
15 
0 
44 
0 
0 
0 
-
54 
0 
(13-40) 
(8-24) 
(1-10) 
(2-8) 
(24-40) 
(30-34) 
(0-6) 
(13-33) 
(6-24) 
(25-63) 
(0-2) 
(24-96) 
given in paren 
Irrigation 
fluid 
-
_ 
0 
0 
33 (27 
-
7 (6-
8 
-
12 (9-
-
-
-
-
9 (3-
-
2 (Ι­
Ο (Ο­
ΙΟ (4-
100 
-
52 (11 
0 
0 
-
0 
10 (6-
-
-
0 
itheses . 
-40) 
9) 
22) 
13) 
•3) 
1) 
•16) 
-104) 
15) 
Tumor cell 
suspensions 
0 
22 
27 
8 
69 
14 
1 
85 
16 
9 
11 
4 
119 
77 
-
5 
3 
-
100 
70 
17 
15 
0 
-
0 
-
75 
0 
0 
(14-27) 
(12-45) 
(0-26) 
(52-93) 
(10-19) 
(75-95) 
(5-39) 
(5-12) 
(4-16) 
(2-6) 
(88-145) 
(61-105) 
(2-6) 
(0-7) 
(50-89) 
(15-22) 
(9-25) 
(71-78) 
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TABLE II shows the correlation of tumor grade and the number of 
colonies produced in soft agar culture. The available data sug-
gest that the results are consistent with the assumption that 
with increasing tumor grade the plating efficiency increases 
also. But additional experience is needed to document this pos-
sibility. 
After termination of the culture, at least one culture plate 
from all samples showing growth was evaluated by examining a 
PAS-stained agar layer containing colonies. In all cases the 
morphology of the cells comprising the tumor colonies in agar 
was clearly recognizable as originating from transitional cell 
carcinoma. Cytopathologic grading of the tumor colonies grown 
in agar agreed in most cases with the grade of tumor as found 
in the histologic material. In HE-stained paraffin block mate-
rial from a biopsy of a grade II-III transitional cell carci-
noma, the cell nest shown in figure 1 is very similar histo-
logically and cytologically to the tumor cell colony shown in 
figure 2, which was grown in soft agar from cells obtained 
from a urine sample of the same patient (3 weeks in culture). 
DISCUSSION: 
The present data demonstrate that évaluable growth of human 
transitional cell carcinoma colonies in double-layer soft agar 
culture can be obtained from urine samples, bladder irrigation 
fluid and tumor biopsies. Compared with bladder irrigation 
fluid cultures, the number of colonies produced from urine is 
in the same range, but both are inferior to the number of colo-
nies produced in tumor cell suspension cultures prepared from 
solid tumors obtained by TUR. A major problem with the use of 
tumor biopsy material is to obtain a representative sample of 
tumor. It is possible that the exophytic part, used for culture 
in the present series, shows a different behavior in culture 
than the deep, sometimes infiltrating, part of the tumor. 
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The technically most demanding application of the HTC3 is the 
in vitro evaluation of tumor sensitivity and resistance to che-
motherapeutic agents. This application requires a low between 
plate variability of the number of colonies and a low infection 
rate. Infection can be introduced in culture by using in vivo 
infected tumor material, or during the course of sample prepa-
ration and incubation of the culture plates. Occult bacterial 
colonization of bladder tumors has been described (Appell et 
al., 1980) which may be responsible in part for the high in-
fection rate in our material. 
Since growth of at least 30-40 colonies/control plate (non-drug 
incubated) is necessary to recognize reproducibly significant 
sensitivity or resistance to chemotherapoutic agents, cultures 
from urine samples are still inadequate for this application of 
HTC3. 
However, a second application of the HTC3, determining "viable" 
or clonogenic tumor cells to assess the effectiveness of thera-
py (Herman et al., 1983a), is clearly feasible with urine cul-
tures. If growth of transitional cell carcinoma colonies in 
cultures is found after therapy, tumor cells with proliferative 
potential clearly remain. With cytological examination of the 
cells in urine, if therapy effects are found it is not clear 
whether the remaining tumor cell still have a potential to re-
plicate in vivo. With repeated cell cultures from urine, we try 
to investigate the biological behavior of these remaining tumor 
cells during and after therapy. It is not yet clear how this 
information can help to improve clinical management of the pa-
tient with transitional cell carcinoma. Prospective trials have 
to be initiated for further evaluation. Evaluation of a negati-
ve post-therapy soft agar culture is difficult because of the 
relatively low growth rates of tumors in soft agar in general. 
Further improvement of the HTC3 technique may provide a partial 
solution to this problem. In addition, urine sample collection 
is noninvasive which makes frequent repeated culturing possible. 
Low stage transitional cell carcinoma of the bladder, where 
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treatment regimens with intravesical chemotherapeutic agents 
are proposed to prolong the recurrence-free interval (Soloway, 
1980: Schulman et al., 1981), can be studied with the HTC3 
technique in a randomized prospective trial. In this form of 
prospective trial all tumors are cultured and sensitivity and/ 
or resistance assessed if possible. 
All patients treated are followed with repeated urine cytology, 
cystoscopy and culturing of urine in HTC3 to assess tumor ac-
tivity. Comparing these methods, the value of repeated cultu-
ring of urine in HTC3 as a means to search for viable tumor 
cells can be seen. 
Further evaluation of patient prognosis can be made by studying 
the growth pattern of tumor colonies in HTC3. Evaluable growth 
parameters include the number of colonies and size distribution 
of colonies with time, all of which can be investigated in re-
peated cultures. For this purpose manual counting of colonies 
with an inverted microscope is not adequate (Kressner et al., 
1980; Herman et al., 1983b). The availability of an automated 
colony counter, which gives not only a total number of colonies 
but also size distributions, makes more sophisticated growth 
studies possible. 
In the management of transitional cell carcinoma it is of great 
value to identify those aggressive tumors which will readily 
metastasize and treat them more aggressively than the tumors 
that have a more "benign" prognosis. Thus, the relative ease 
of culturing transitional cell tumor colonies from urine, blad-
der irrigation fluid and tumor biopsies may allow HTC3 evalua-
tion to make significant contributions to patient management 
throughout the entire course of the disease. 
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ABSTRACT: 
Human carcinoma tissues were grown in culture for two to four 
weeks using the two-layer soft agar technique. All cultures 
that showed growth of tumor cell colonies also showed well-
preserved, apparently healthy tumor cells lying singly. 
These cells showed neither proliferative capacity nor necro-
sis or morphologic degeneration during the time in soft agar. 
Thus, morphologic criteria seem to be poor indicators of 
tumor cell proliferative potential, at least in the short 
term. However, the method of soft agar tumor clonogenic cell 
culture itself provided a direct measure of tumor cell pro-
liferative capacity, ie, the formation of colonies from sin-
gle tumor cells. This may be valuable in directly assessing 
the presence of "viable" tumor cells m biopsy specimens 
taken after therapy, and thus guide further patient therapy. 
(Arch Pathol Lab Med 1983; 107: 81-83) 
INTRODUCTION: 
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It is common practice in oncology to take biopsy specimens from 
areas of tumor localization to assess the effectiveness of the-
rapy. In these situations, the pathologist is often asked if 
"viable" tumor cells appear in the specimen. To respond to this 
question, the pathologist may attempt to evaluate the viability 
of tumor cells by morphologic characteristics, especially 
nuclear and chromatin preservation. Both the pathologist and 
the oncologist usually are well aware of the severe limitations 
of this method. However, because the reliable diagnosis of per-
sisting viable tumor cells can potentially be a major contribu-
tion to choice of further therapy, better insight into the cri-
teria for evaluation of posttherapy biopsy specimens would be 
of value to both the pathologist and the clinician. 
The growth of human solid tumors in soft agar (1) recently pro-
vided a unique opportunity to study the biology of human tumor 
cells of proven proliferative capacity. The clinical applica-
tions of this technique have primarily been directed at in vi-
tro evaluation of chemotherapeutic responsiveness or resistance 
of tumors as a potential guide for individualizing the choice 
of a chemotherapy regimen in vivo (2,3). We studied tumor cell 
morphologic structure in soft agar culture, and its relevance 
to the problem of posttherapy evaluation of tumor biopsy speci-
mens . 
MATERIALS AND METHODS: 
One hunderd thirty-six human tumors, primarily carcinomas, were 
cultured, using the two-layer soft agar method (1), in the de-
partment of pathology. Radboud Hospital, Nijmegen, the Nether-
lands. Routine surgical specimens of solid tumors were brought 
sterile and unfixed to the department of pathology. 
Using sterile technique, a pathologist examined the material 
and chose tissue for soft agar culture (approximately 1 to 2 g) 
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and routine histopathologic study. 
Tissue selected for soft agar culture was further processed ac-
cording to the detailed description recently published (1). 
Briefly, the tissue was minced with scissors for five minutes 
through a metal sieve of approximately ten holes per square 
centimeters into McCoy's wash medium. The suspension of cells 
was then syringed once manually through a 25-gauge, 2.5-cm 
needle and washed twice in McCoy's medium. The percent of trypan 
blue-excluding cells was determined using 0.1 mL of the cell 
suspension « 5 % to>95% in the present material) and the con-
centration of nucleated cells determined in a hemocytometer. 
The concentration of cells was then adjusted to 3x10 nucleated 
cells per milliliter of McCoy's wash medium. Culture dishes, 35 
mm, were seeded with 5x10 nucleated cells per dish in double-
layer soft agar, exactly as described elsewhere (A), except 
that conditioned medium was not used. Culture dishes were 
examined within 2A hours after plating to evaluate presence of 
clumps seeded into culture, and to rule out infection of the 
culture. Colonies of tumor cells were examined beginning one 
week after plating. 
Air-dried, Papanicolaou-stained smears of the cell suspension 
used for plating the cultures allowed morphologic assessment of 
the cell composition and morphologic structure of the cell 
types brought into culture. After the growth of colonies, de-
tailled morphologic assessment of the colonies as well as of 
other cells or particles in the agar was carried out on agar 
layers removed from the culture dishes, mounted on standard 
glass slides, and stained with PAS. 
RESULTS: 
Of the 136 tumors cultured, 54 grew in the culture system, 
growth being defined as five or more colonies of 30 or more 
cells per dish. Examination of the cultures 24 hours after pia-
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ting showed distributions of tumor cells, interstitial cells, 
and inflammatory cells that exactly reflected those seen on the 
Papanicolaou-stained smears of single-cell suspensions. Further 
growth of colonies showed development of three-dimensional cell 
groups with smooth borders (Figs 1 and 2). 
The most striking observations on these cultures resulted from 
examination of the PAS-stained agar layers after termination of 
the cultures. In all cultures that showed colony growth, exami-
nation of the colonies after two to four weeks showed that 
they consisted of tumor cells with the same characteristics as 
the tumor cells observed in the preculture, single-cell suspen-
sion. The colonies displayed morphologic features comparable 
with the histologic slides of the tumors. Figure 1, left, shows 
a mucinous adenocarcinoma found in the tunica albugínea of a 
67-year-old man. Figure 1, center, shows a tumor cell colony 
from this same tumor after three weeks' growth in soft agar. 
The smooth border of tumor cell colonies developed in agar is 
apparent. The morphologic characteristics of the tumor cells 
in soft agar culture reproduced exactly those seen in the ori-
ginal histologic slides (Fig 1, left and center). Figure 2, 
left, shows a well-differentiated squamous cell carcinoma of 
the sublingual region metastatic to a cervical lymph node in a 
76-year-old woman. Figure 2, center, shows a colony of cells 
from this tumor alter four weeks' growth in boft agar culture. 
The similarity of cell features, as well as the formation in 
culture of a squamous nest similar to those seen in the origi-
nal histologic structure, are apparent. Large colonies (more 
than 100 cells) often showed pyknotic tumor cells in the middle 
of the colony after three to four weeks in culture. We have not 
observed growth of fibroblast or hematopoietic colonies, in 
agreement with the observations of others (1). 
Of special importance is the observation of single tumor cells 
(not located within colonies) in the agar layers after two to 
four weeks in culture. These tumor cells are well preserved 
and show the same nuclear and cytoplasmic features as tumor 
cells in colonies. Particularly noteworthy are the well-preser-
ved chromatin structure and nuclear and cytoplasmic boundaries 
Fig. 1.- Mucinous adenocarcinoma metastatic to tunica albugínea of testis of 67-year old man. Primary was unknown. 
Left, Initial specimen (hematoxylin-eosin, original magnification x40). Center, Colony of tumor cells grown in soft 
agar from tumor shown at left, after three weeks in culture (PAS, original magnification x50). Right, Single well-
preserved adenocarcinoma cell in same soft agar culture as colony shown at center (PAS, original magnification xlOO). 
Fig. 2.- Cervical lymph node biopsy specimen with metastatic squamous cell carcinoma of sublingual origin in 76-year 
old woman. Left, Initial specimen (hematoxylin-eosin, original magnification x50). Center, Soft agar culture of squa-
mous cell carcinoma shown at left, after four weeks in culture. Cytologic and histologic features of in vitro tumor 
cell colony reproduce those seen in biopsy material (PAS, original magnification x50). Right, Single well-preserved 
squamous carcinoma cell in same soft agar culture plate as tumor cell colony shown at center. Excellent morphologic 
preservation of cell after four weeks in agar is apparent (PAS, original magnification xlOO). 
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(Figs 1, right, and 2, right). Figure 1, right, shows an adeno-
carcinoma cell in the same agar layer as the tumor cell colony 
in Fig 1, center. The cell lies singly, clearly is well preser-
ved, and shows cytologic features that make it readily identi-
fiable as an adenocarcinoma cell. This cell is morphologically 
identical to the cells in the tumor cell colony (Fig 1, center), 
However, this and similar cells demonstrated no proliferative 
potential during the three weeks in soft agar culture. Simila-
ry, Fig 2, right, shows a single, well-preserved, squamous car-
cinoma cell from the same soft agar culture as the colony in 
Fig 2, center. In both cultures (Figs 1, right, and 2, right), 
the well-preserved single tumor cells are surrounded by necro-
tic debris and ghosts of tumor, inflammatory and stromal cells 
originally seeded into the agar culture. 
COMMENT: 
The present study demonstrated that cells may remain morpholo-
gically well preserved for up to a month in soft agar culture 
without demonstrating any proliferative capacity. Because pro-
liferative capacity is the most important definition of viabi-
lity in terms of tumor therapy, morphologic preservation or 
even ability to incorporate metabolites, exclude dye, or other 
commonly used measures of cell viability may in fact be mis-
leading in evaluation of clinical tumor material. 
The conditions of cell growth in soft agar culture clearly are 
highly artifactual when compared with those of in vivo tumor 
growth. Cells that remain well preserved by morphologic criteria 
but do not proliferate in soft agar culture may well retain the 
potential for growth in vivo. As dormant tumor cells, they may 
in fact be responsible for eventual regrowth of tumor after 
therapy. However, because of the serious consequences for the 
patient, the present observations emphasize that the morpholo-
gic characteristics of cells should be regarded as an unrelia-
ble indication of their proliferative potential. Thus, basing 
an assessment of viable tumor cells on the examination of rou-
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tine cytologic or histologic preparations is clearly beyond 
the capabilities of routine pathologic techniques. Most patho-
logists and oncologists are aware of this limitation of morpho-
logic methods. The frequency with which the question of viable 
tumor cells in posttherapy biopsy specimens is posed, however, 
indicates the importance of finding a more reliable technique 
with which to provide an answer. 
Thus, a more optimistic second conclusion may be drawn from the 
present observations. Colonies of tumor cells are easily recog-
nizable in soft agar culture and their presence indicates that 
tumor cells of relatively robust proliferative ability, a 
direct and compelling measure of viability, were present in the 
original material from the patient. A reliable positive answer 
to the oncologist's question of whether viable tumor cells were 
present in a biopsy specimen can be given if tumor cell colo-
nies are produced from the biopsy material in soft agar culture. 
This demonstration of robustly proliferating tumor cells in 
posttherapy biopsy specimens is, to our knowledge, new informa-
tion. The further questiono of how this information can be used 
in patient management and wether this information can in fact 
have a significant effect on reducing patient morbidity and 
mortality must be answered in parallel and prospective clinical 
trials . 
Similary, the meaning of no growth in posttreatment soft agar 
culture, (negative results), especially in cases where cytolo-
gic or histologic material shows evidence of tumor cells, 
remain to be defined. The prospects for obtaining reliable ne-
gative data from the soft agar technique, given the relatively 
low growth rates of tumors in this system (1), heavily depend 
on further development of the system through better understan-
ding of the growth conditions of various tumor types. The pre-
sence after two to four weeks in soft agar of tumor cells that 
appear healthy yet do not proliferate may be ambiguous. Either 
these cells are dormant and retain the capacity to reenter the 
cell cycle and proliferate, or they may be in fact end stage, 
possibly retaining metabolic capacity, but without further pro-
liferative capacity. This and similar questions that relate in 
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vitro and in vivo behavior are presently subjects of continuing 
investigation. 
Finally, the present series demonstrated that the human tumor 
clonogenic cell culture technique was relatively easy to im-
plement in, and integrate into, the routine work of a patholo-
gy laboratory. In addition to determining sensitivity or re-
sistance of tumors to chemotherapeutic agents, this system is 
potentially applicable to other problems in routine treatment 
of tumor patients. 
REFERENCES: 
1. Salmon SE (ed): Cloning of Human Tumor Stem Cells, New York, 
Alan R. Lias Ine, 1980. 
2. Hamburger AW: Use of in vitro tests in predictive cancer 
chemotherapy. JNCI 1981; 66: 981-988. 
3. Selby PJ, Raghavan D: Role of laboratory chemosensitivity 
testing in the selection of cancer chemotherapy for indi-
dual patients. J Clin Pathol 1981; 34: 455-463. 
4. Salmon SE, Hamburger AW, Soehnlein B, et al: Quantitation 
of differential sensitivity of human-tumor stem cells to 
anticancer drugs. N Engl J Med 1978; 298: 1321-1327. 

CHAPTER 5. 
IN-USE EVALUATION OF THE OMNICON AUTOMATED 
TUMOR COLONY COUNTER. 
Chester J. Herman, Olga E. Pelgrim, Wim J. Kirkels, 
Rene Verheijen, Frans M.J. Debruyne, Peter Kenemans 
G. Peter Vooijs. 
Departments of Pathology, Urology and Gynaecology 
of the Radboud Hospital, Catholic University, 
Nijmegen, the Netherlands. 
Reprinted by permission from 
Cytometry, 1983, 3, no:6: page 439-Д42. 
Copyright 1983 by Society for Analytical Cytology, 
Baltimore. 
68 
ABSTRACT: 
The reproducibility and accuracy of the Omnicon (Bausch and 
Lomb Inc., Rochester, NY) automated tumor colony counter for 
counting tumor colonies growing in double layer soft agar is 
evaluated and the reproducibility is compared with manual 
tumor colony counting. Replicate within day run-to-run colo­
ny counts of the Omnicon show a median correlation coeffi­
cient (г) У 0.985, and day-to-day median r of > 0.980. In 
contrast, for manual colony counting, the best intra-obser-
ver reproducibility achieved is a r of 0.943 and the best 
inter-observer reproducibility is a r of 0,831. Analysis 
of results from individual culture plates counted by the 
Omnicon on 5 separate days shows a median coefficient of 
variation of colony counts over 5 days of less than 20%. 
Counting of culture plates during incubation shows that the 
Omnicon is counting tumor colonies developing after plating 
of a single cell suspension. 
Key terms: Clonogenic culture, tumor colonies, tumor cloning, 
soft agar culture. 
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INTRODUCTION: 
The recent development of short-term culture of human primary 
tumors has offered the clinical laboratory the possibility of 
monitoring dynamic rather than static properties of human tumor 
cells. Specifically, the human tumor cloning system (HTCS) 
applied to solid tumors by Salmon et al., allows the growth in 
a two-layer soft agar system of tumor colonies from clonogenic, 
presumptive "stem" cells.(5,6) The first proposed application 
of this system to clinical oncology was the in vitro determina-
tion of chemotherapeutic sensitivity and resistance of tumors 
to allow individualizing of chemotherapeutic regimens.(5) 
Further clinical applications have been proposed, including 
posttherapy evaluation of persistent or recurrent tumor (1) 
and evaluation of grade and stage of tumor based on in vitro 
growth characteristics.(2) 
Soon after the potential clinical usefulness of the HTCS was 
recognized, an automated tumor colony counter was developed 
(3) to speed up the process of counting colonies and determi-
ning chemotherapeutic drug resistance or sensitivity by compu-
tation of the inhibition of colony growth produced by prein-
cubation of cell samples with cytostatic agents. Since the 
automated colony counter also gives information on the size 
distribution of tumor colonies, additional data bearing on 
tumor colony growth parameters in vitro have become available 
and are potentially useful new data which may contribute to 
all of the proposed clinical applications of HTCS cited here. 
However, before the full potential of the automated colony 
counter can be realized, the reproducibility and accuracy of 
its basic function of counting tumor colonies in soft agar 
culture must be established. The present report deals with 
initial in-use experience with the automated colony counter. 
70 
MATERIALS AND METHODS: 
In the Pathology Department of Radboud Hospital, all urologie 
and gynecologic tumors received are cultured by the two layer 
soft agar method. Routine surgical specimens of solid tumors 
are brought sterile and unfixed to the Department of Patholo-
gy. A pathologist using sterile technique examines the mate-
rial and chooses tissue for soft agar culture (approximately 
1-2 g) and routine histopathology. Tissue selected for soft 
agar culture is further processed according to the detailed 
description recently published.(6) 
Briefly, the tissue is minced with scissors for 5 min through 
a metal sieve of 60 holes/inch into McCoy's wash medium. The 
suspension of cells is then treated with collagenase and DNase 
for 2 hr (7), syringed manually once through a 25 g 1 inch 
needle and washed twice in McCoy's medium. Trypan blue-exclu-
ding cells are determined using 0.1 ml of the cell suspension, 
and the concentration of nucleated cells is determined in a 
Burker-Turk haemocytometer. The concentration of cells is then 
adjusted to 3x10 nucleated cells/ml McCoy's wash. Culture 
dishes (35 mm) are seeded with 5x10 nucleated cells per dish 
in double layer soft agar exactly as described elsewhere (5) 
except that conditioned medium is not used. Culture dishes are 
examined within 24 hr after plating to evaluate presence of 
clumps seeded into culture and to rule out infection of the 
culture. Colonies of tumor cells are examined beginning 1 week 
after plating. A colony of tumor cells is defined as a spheri-
cal three-dimensional cellular aggregate with smooth borders 
containing 30 or more cells.(1) 
Air-dried Papanicolaou stained smears of the cell suspension 
used for plating the cultures are made from all specimens. 
These smears allow visual assessment of the cell composition 
and morphology of the cell types brought into culture. Follow-
ing the growth of colonies, detailed morphologic assessment of 
the colonies as well as other cells and particles in the agar 
is carried out on agar layers removed from the culture dishes, 
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mounted on standard glass slides, and stained with the periodic 
acid Schiff (PAS) reaction. From selected cultures, formalin-
fixed paraffin blocks are made and 4-6 um sections are prepared, 
similar to routine histologic preparations. (4) These sections 
are stained with haematoxylin and eosin as well as other routine 
histologic stains as appropriate for the type of tumor. 
Automated colony counting: 
The Omnicon (Bausch and Lomb Inc., Rochester, NY) was used for 
the present evaluation of automated colony counting. A detailed 
description of the theory and operation of this instrument has 
been published.(3) The instrument used in the present work was 
similar to that previously described except that it was fitted 
with an inverted microscope and a fully automatic 36-dish mi­
croscope stage. This allowed walk-away operation with counting 
of 36 culture dishes taking an average of 40-45 m m . 
For the present study, culture dishes from the routine workload 
of the laboratory including a spectrum of both gynecologic and 
urologie tumors were fixed in 4% glutaraldehyde. These cultures 
were unselected except that an attempt was made to include cul­
tures showing the full range of colony counts: <^30 to "^ІЗОО 
colonies/plate. For automated analysis, 108 culture dishes were 
counted by the Oramcon as three 36-dish sets. For determination 
of within day run-to-run reproducibility, the sets were counted 
twice in successsion with no changes in position of the dishes, 
settings of the instrument controls, etc. A total of 13 diffe­
rent within day comparisons were made on different days. For 
determination of day-to-day reproducibility, the same 108 cul­
ture dishes as 36-dish sets were counted five times on 5 or 6 
different days over a period of 8 days with demounting and re­
mounting of the cultures as well as readjustment of the illumi­
nator source and scanner sensitivity each day. This provided a 
total of 35 different day-to-day comparisons. Care was taken 
however, to orient the culture dishes identically each day using 
an indelible ink mark on the side of the culture dish. Because 
of drying and cracking of the agar layers with ageing, ( m spite 
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of glutaraldehyde fixation, hydration and refrigeration of the 
culture dishes) 29 of the culture dishes became unusable during 
the course of the study leaving a total of 79 culture dishes 
from which évaluable data were obtained. 
Manual colony counting: 
For comparison with automated colony counting, 155 culture 
dishes were counted by three different observers working in the 
culture laboratory and responsible for routine counting of co-
lonies. For technical reasons, primarily deterioration and 
drying of the agar, these culture dishes were not the same 
dishes used for Omnicon counting but were from the same types 
of material with a similar distribution of numbers of tumor 
cell colonies. All colony counting was done with the culture 
plates coded so that the observer did not know whether or not 
he had seen the culture plate previously, nor did the observer 
know the results of previous counts, if any. 
RESULTS: 
Omnicon reproducibility: 
Figure 1A shows the distribution of r values of duplicate Omni-
con counts on the same day, each point representing one 36-dish 
set. The modal г value is } 0.990 and median r value is •> 0.985. 
The day-to-day r values of automated colony counting are pre­
sented in Figure IB. Each point represents the г value of colo­
ny counts from one of the three 36-dish sets on 1 day with 
counts obtained from the same set on 1 of the other days. Thus, 
each day's colony count is compared with every other day's 
count for each of the sets of 36-dishes. The modal day-to-day 
г value is > 0.990 and the median > 0.980. 
Since the distribution of both run-to-run and day-to-day r 
values showed considerable skewness with several day-to-day 
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r values less than 0.750, the variability of Omnicon counting 
was evaluated individually for each culture plate. Figure 2 
presents the distribution of coefficients of variation (cv) 
for each culture dish computed from the colony counts on 5 
different days. The modal cv is 6%, the median cv 10%, and 
61 of the 79 évaluable culture dishes show a cv of automated 
counting less than 20%. When the mean number of colonies per 
dish is compared with the cv, a tendency to lower cv with 
higher colony counts is seen in all three test sets (r=-0.115, 
-0.217, and -0.380). 
Reproducibility of manual counting: 
For comparison with automated colony counting, 155 culture 
dishes were counted by at least two observers and/or by the 
same observer twice to assess intra- and inter-observer va-
riability. Table I presents the results of these studies. 
The best reproducibility is achieved by observer A counting 
the same plates twice. Observer С also shows good reprodu­
cibility with duplicate counting of the same culture dishes 
(consistency), but clearly produces very different results 
from observers A and B. Observer A had, at the time of the 
present study, 1.5 yr experience with the soft agar culture 
technique after training in one of the most active and ex­
perienced HTCS laboratories. Observers В and С were trained 
by observer A and all three observers count culture plates 
routinely in our laboratory. It is clear that the best re­
producibility achieved by manual counting falls short of 
that achieved by automated counting. In addition, the inter-
observer variability is such as to call into question the 
use of data in a laboratory where more than one observer 
counts culture dishes. 
Comparison of automated and manual counting: 
All culture plates counted by t 
observer A. The r value for the 
comparing automated and manual 
he Omnicon were also counted by 
three sets of culture dishes 
counting were 0.513, 0.630 and 
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0.891, respectively, similar to the inter-observer reproducibi-
lity shown by manual counting (Table I). In general, the manual 
counts were lower by factors of 2 to 5 than the Omnicon counts 
(Discussion) . 
Accuracy of automated colony counts: 
Because of the poor correlation of manual colony counts by dif-
ferent human observers, the accuracy of the Omnicon was assess-
ed independently of manual counting. The essential question to 
determine the accuracy of automated colony counting is whether 
the automated counts reflect development of tumor colonies in 
culture over time, dependent only on the presence of living 
cells in the original cell suspension. Table IT shows an exam-
ple of such a study. MatLyLu rat prostate carcinoma cells, main-
tained in our laboratory, were planted in soft agar culture. 
Because of the high plating efficiency and rapid growth of this 
3 
undifferentiated tumor, 5x10 cells were used per culture plate 
in place of the 5x10 cells used for human primary tumors. As 
controls, MatLyLu tumor cells were prefixed in neutral buffered 
formalin for 2 hr, washed twice with PBS and planted in culture. 
During incubation, pairs of culture plates were removed from 
culture and counted (Table II). Because of high likelihood of 
infection of the culture plates during the time they were being 
counted by the Omnicon in an open laboratory and the subsequent 
risk of infection of other cultures in the incubator, the plates 
were not reincubated after counting. Thus, the data points in 
Table II represent different pairs of culture plates from the 
same tumor cell suspensions, processed and set in culture at 
the same time 
As shown in Table II, the Omnicon counted no colony development 
in the culture plates planted with formalin-fixed cells, while 
the unfixed cells formed microscopically verified colonies over 
9 days in culture. The development during 3 weeks incubation of 
Omnicon-counted tumor colonies from a human breast carcinoma is 
also shown in Table II. Colony growth is slower and the plating 
efficiency is lower in primary human tumor cultures. 
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TABLE I. INTER-OBSERVER REPRODUCIBILITY OF MANUAL TUMOR COLONY 
COUNTS3. 
Observer 
A В С 
A 0.943 (25) b 0.831 (150) 0.478 (114) 
В 0.733 (18) b 0.643 (110) 
С 0.929 (15) Ь 
Correlation coefficient (number of culture plates). 
Pooled data for 3 observers, each observer counting the same 
culture plate twice: total N=58; r=0.877. 
TABLE II. DEVELOPMENT OF TUMOR COLONIES IN SOFT AGAR CULTURE3 
Days in 
cui ture 
1 
2 
3 
6 
9 
10 
13 
16 
19 
21 
MatLyLu 
Formalin 
fixed 
3±0 
2±1 
2 + 2 
Rat C a r c i n o m a 
Unfixed 
0±0 
419±40 
521±136 
Human Breast 
Carcinoma 
Pleural Fluidc 
4±1 
12 + 3 
22±2 
45±10 
45±3 
43±1 
60+7 
70±35 
Mean ±SE; two culture plates per data point. Omnicon counts 
5x10 Cells plated per culture dish. 
с 5 
5x10 Cells plated per culture dish. 
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DISCUSSION: 
The present study indicates that the Omnicon automated tumor 
colony counter functions with a high reproducibility. The 
median within day run-to-run r of ^ 0.985 and median day-to­
day г of у 0.980 are significantly better than the reproduci­
bility achievable by manual colony counting (Table I). 
In order to achieve this reproducibility, instrumental vari­
ables must be carefully controlled. The most sensitive hard­
ware component of the Omnicon is the light source. It is im­
portant that the light source be adjusted each day such that 
the maximum illumination, judged by level of TV-scanner satu­
ration, is as high as possible and the same from day-to-day. 
It was noted in the present study that increased variability 
in colony counts was recorded just before the light bulb bur­
ned out. The addition of a feedback circuit for monitoring 
light intensity at the field of view might obviate this prob­
lem . 
The cultures which were subject to high day-to-day cv were 
examined manually and compared with cultures producing low 
variability. The single most important cause of lack of day-
to-day reproducibility of colony counts of individual culture 
dishes is the presence of tumor colonies at different levels 
in the agar layers. The most common levels of colony growth 
seem to be the upper and lower agar layers. Two or more layers 
of tumor cell colonies in a single culture dish seem to cause 
difficulties with the automatic focussing of the Omnicon such 
that different planes of focus are chosen from run to run and 
day to day, with inevitable variability in colony counts re­
sulting. Preliminary manual inspection of culture dishes to 
ascertain that the level of colony growth within the culture 
dish is reasonably uniform should eliminate many of the cul­
ture dishes which give high cv with automated counting. 
The observation that day-to-day cv tend to be inversely relat­
ed to tolony count in individual culture dishes may also be 
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related to problems with the automated focussing of the Omnicon. 
If the number of tumor cell colonies in a culture dish is so 
low that the instrument does not have a tumor cell colony to 
use for focussing in the first field examined, variable planes 
of focus will be used from run-to-run. A minimum threshold 
number of colonies per culture dish as a prerequisite for ac-
cepting Omnicon counts may help in eliminating from automated 
counting those culture dishes which show higher variability. 
The Omnicon rejects fields of view from counting if the total 
optical density of the field is too high. In the present study, 
data from a particular culture dish were not included m the 
statistics if 10 or more fields(of a total of 35 scanned per 
culture plate) were rejected because of high optical density. 
This was an arbitrary choice based on counting statistics; 
further refinement of this threshold for rejecting Omnicon 
counts may be possible. 
The most difficult probier in evaluating Omnicon results and 
comparing them with manual counting of tumor cell colonies is 
the question of accuracy. The most widely accepted present de-
finition of a tumor cell colony in the double layer soft agar 
system is a reasonably regular round structure composed of 
30 to 50 or more cells. Since identification by inverted phase 
microscopy of individual cells in colonies is difficult, it 
seems that in practice the most important criterion used by la-
boratory personnel is colony size. Since the size of a tumor 
colony composed of 30 cells can vary significantly depending 
on the tumor type, the number of cells actually required to 
meet the definition of tumor cell colony may vary both among 
human observers and for the Omnicon. This may explain in large 
part the poor inter- and intra-observer reproducibility of 
manual counting as well as the poor correlation between the 
Omnicon and manual counting.(3) During the initial phases of 
the present study, comparison of Omnicon and manual counts and 
further examination of fixed, PAS stained agar layers demon-
strated that our laboratory's criteria for tumor colonies had 
become too stringent, requiring in practice 100 or more cells 
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for a structure to be accepted as a tumor colony. 
The tumors used in the present study to evaluate Omnicon per-
formance included a range of gynecologic and urologie tumors. 
Since the individual tumor cells of different tumor types vary 
widely in size, a tumor colony in agar composed of 30 cells 
will also vary in size. Thus, for optimal tumor colony count-
ing, the size threshold accepted by the Omnicon may need to 
be varied depending on the specific tumor type. 
The fact that growth of tumor colonies in agar during the p e n 
od of incubation is clearly reflected in automated counts from 
a rapidly growing animal tumor and from a more slowly growing 
primary human tumor (Table II) supports the interpretation 
that the Omnicon is counting tumor colonies from two very dif-
ferent tumor types. Since colonies are not recognized by the 
Omnicon during incubation of formalin-fixed cells in the soft 
agar system, artefacts such as drying or cracking of the agar 
do not seem to contribute to the colony count produced by the 
Omnicon. 
In general the reproducibility of the Omnicon is adequate for 
routine use in counting of tumor colonies in soft agar, and is 
clearly better than the reproducibility achieved by manual 
counting. Furhter evaluation of this instrument will allow e n 
tena to be formulated to identify the types of cultures and 
properties of specific culture dishes which cause poor reprodu 
cibility of automated counting of specific cultures. The pre-
sent study suggests that these may constitute approximately 
20% of the total culture dishes in a routine tumor cloning la-
boratory. The remaining 80% of cultures, évaluable by automate 
colony counting, will also provide additional data of potentia 
value such as colony size distribution during growth in cultur 
and changes in size distribution caused by chemotherapeutic 
agents. This additional data is unavailable from manual counti 
from manual counting techniques. 
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INTRODUCTION: 
The ability to grow primary human solid tumors in two-layer 
soft agar culture has provided a number of new opportunities in 
clinical oncology (Hamburger and Salmon, 1977; Hamburger, 1981; 
Salmon et al., 1978; Salmon, 1980). The initial clinical appli-
cation of this technique was the in vitro testing of tumor sen-
sitivity or resistance to chemotherapeutic agents, as a way 
both of tailoring chemotherapy regimens to individual patients 
and of testing new cytostatic agents. Newer clinical applica-
tions of the human tumor cloning system (HTCS) currently under 
investigation include monitoring of patients following therapy 
to assess the presence of persistent or recurrent tumor (Herman 
et al., 1983a) and prediction of in vivo tumor behaviour based 
on patterns of growth in vitro (Kirkels et al., 1982). The use 
of the HTCS to predict tumor response to cytostatic agents has 
shown a good correlation between in vitro and in vivo resistan-
ce (approx 90%) while correlation of in vitro with in vivo sen-
sitivity has remained somewhat lower, 60-70% (Von Hoff et al., 
1981; Selby et al., 1983). 
As experience with the HTCS has accumulated in a number of la-
boratories , problems with the clinical applications of the 
system have been identified (see Selby et al., 1983, for review), 
Possibly the most serious problem preventing widespread clini-
cal application of the HTCS is the relatively low percentage of 
primary human tumors which show évaluable growth m the system, 
varying from 25-50% depending on tumor type and source of start-
ing material. In addition, preparation of a good suspension of 
single cells, generally considered an absolute necessity as 
starting material for the HTCS, is a persistent problem (Herman 
et al., 1976, 1979; Selby et al., 1983) for a number of solid 
tumor types . 
In seeking solutions to these problems, as well as a better un-
derstanding of the process of tumor colony formation in soft 
agar, we have investigated the temporal patterns of growth of 
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both animal model tumors and primary human solid tumors in the 
HTCS. 
MATERIAL AND METHODS: 
In the Pathology Department, Radboud Hospital, all urologie and 
gynecologic tumors received, and tumors from other departments 
in cases of special interest, are cultured by the double-layer 
soft-agar method. All tumor samples, routine surgical specimens, 
urines, bladder irrigation fluids, pleural fluids and ascites, 
are brought sterile and unfixed to the Pathology Department. 
Urines and irrigation fluids from patients with transitional-
cell carcinoma of the bladder who were undergoing transurethral 
resection of their tumor were collected in sterile urine bags 
through the cystoscope sheath before resection was started,as 
recently described (Kirkels et al., 1982). Pleural effusions 
and ascites were collecte' in sterile heparinized vessels. 
After collection, urines, bladder irrigation fluids and effu-
sions were transported to the Pathology Department within 15 
min. The fluids were transferred to sterile 50 ml centrifuge 
tubes and spun for 15 min at 400 g, then the supernatant was 
discarded and 10-20 ml McCoy's 5A medium (GIBC0 Europe) with 
10% fetal calf serum and 1% pen/strep (McCoy's wash) were added 
to the cell pellet. After thorough vortexing, the cell suspen-
sions were combined into one tube. After another washing of the 
cells, McCoy's wash was added to the cell pellet, 2-5 ml accord-
ing to the estimated number of cells, and the specimens were 
processed further as described below for cell suspensions from 
solid tumor. 
Solid tumor specimens were received sterile and unfixed at the 
Pathology Department and examined by a pathologist using ste 
rile technique. Material was selected for soft-agar culture and 
for routine histopathology. Tissue chosen for soft-agar culture 
was further processed according to the detailed description re-
cently published (Salmon, 1980). Briefly, the tissue was minced 
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with double-blunt scissors in a sterile 50-ml centrifuge tube 
for 10 min in McCoy's wash medium. After centrifugation of the 
tumor mince (10 min, 400 g ) , the supernatant was discarded and 
the remaining tumor mass treated with collagenase Type II and 
DNase Type I for 2 h at 370C (Slocum et al., 1981). Following 
incubation, McCoy's wash was added and the cell suspension was 
first passed through a metal sieve of 60 holes per inch. The 
cell suspension was centrifuged, the supernatant discarded and 
the cell pellet resuspended in McCoy's wash. This cell suspen-
sion was then passed through a gas-sterilized nylon filter with 
70- to 100-/um holes (Ortho Diagnostics, Belgium). The cells 
were then washed again and the cell pellet resuspended in 2-5 
ml McCoy's wash according to the estimated number of cells. 
Trypan-blue-excluding cells were determined using 0.1 ml of the 
cell suspension. The concentration of large nucleated cells was 
determined in a hemocytome ter and then adjusted to 3x10 cells 
per ml McCoy's wash. 
For in vitro drug testing, cells were incubated for 1 h in drug 
solutions made up in McCoy's wash to approximately 10% of the 
in vivo attainable peak plasma level (Salmon, 1980). The cells 
for the control group were incubated with McCoy's wash alone, 
omitting the cytotoxic drug. After drug incubation, the cells 
were centrifuged and seeded in 35-mm culture dishes with 5x10 
cells per culture dish in double-layer soft-agar exactly as 
described elsewhere (Salmon et al., 1979) except that condi-
tioned medium was not used. The cultures were then incubated 
at 370C, 6% CO« in a humidified atmosphere. 
All colony counting in the present study was performed using 
the Omnicon automated colony counter (Bausch and Lomb Ine, 
Rochester, NY, USA). This instrument and the choice of its ope-
rating parameters have been described in detail previously 
(Kressner et al., 1980). Briefly, culture plates are illumina-
ted with a white-light source and a television camera produces 
high-contrast images for analysis by a solid-state picture pro-
cessor. This picture processor examines all objects in the 
agar and analyzes their optical density, size and shape. On the 
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basis of preprogrammed logic using these three features, colo­
nies of tumor cells are identified and counted in six size ca­
tegories while artifacts are rejected. Λ 36-dish computer-con­
trolled stage allows walk-away operation with 36 dishes taking 
approximately 45 min to count. The Omnicon has been demon­
strated to be accurate and more reproducible than manual co­
lony counting (Herman et al., 1983b). 
Colony counting for the present study was begun within 1-2 days 
of plating of the tumor specimen and was thereafter repeated 
2-3 times per week for up to 6 weeks, depending on the pattern 
of growth seen in culture. For each time point, at least two 
culture dishes if available were removed from culture, the 
number of colonies determined and the culture dishes fixed in 
glutaraldehyde for further morphologic and/or histochemical 
study. Culture dishes were not in general returned to the in­
cubator following counting because of the risk of infection 
both of the counted dishes thembelves and of other dishes in 
the incubator. Occasional"1", when insufficient numbers of cul­
ture dishes were available from a given tumor, the culture 
dishes were sealed with porous tape and used for multiple 
counting with re-incubation after each count. 
The present report is based on 117 tumor samples. Of these 117, 
25 samples provided enough tumor cells to evaluate drug-pre-
treated as well as control dishes with 1-11 different drugs. 
For each growth curve, control or drug, 6-24 culture dishes, 
generally 24, were used. 
Air-dried Papanicolaou-stamed smears of aliquots of the cell 
suspension used for plating of the cultures were made from all 
specimens. These smears allowed morphologic assessment of the 
cell composition and morphology of the cell types brought into 
culture. Following colony counting of the culture dishes, de­
tailed morphologic assessment of the colonies as well as other 
cells and particles in the agar with increasing time in cultu­
re was carried out on agar layers removed from the culture 
dishes, mounted on standard glass slides (Salmon and Buick, 
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1979), and stained with the Periodic-acid Schiff (PAS) reaction, 
From selected cultures, formalin-fixed paraffin blocks were 
made and A- to 6-um sections were prepared as m routine histo­
logic preparations (Favelle et al., 1981). These sections were 
stained with hematoxylin and eosin as well as other routine 
histologic stains as appropiate for the type of tumor. 
RESULTS: 
Figure 1 demonstrates the growth m soft-agar of an undifferen­
tiated rat prostate adenocarcinoma, MatLyLu, maintained in our 
laboratory. As in all the Figures, three curves are presented, 
representing all tumor cell colonies over 60 um in diameter 
(Д), over 86 urn in diameter (·) and over 12Д um in diameter 
(O ) . Standard error bars are absent if only one culture dish 
was available for counting at a given time point. The pattern 
of growth demonstrated in Figure 1 is typical of what is ob­
served in tumor cell lines, either human or animal. A single-
cell suspension is easily prepared and day 1-2 counts show few 
or no "colonies". Growth begins rapidly after plating, maximum 
colony counts being seen within 2 weeks of plating. Following 
the peak colony count, the number of counted colonies decreases, 
due to decreased optical density of necrotic colonies, which 
prevents their recognition by the Omnicon. The necrotic colo­
nies are easily demonstrated morphologically in the PAS-stained 
agar layers. 
To verify that the development of colonies in agar was real, an 
aliquot of the same tumor-cell suspension was pre-fixed for 1 h 
in 10% neutral buffered formalin, washed in McCoy's wash and 
seeded into agar culture in exactly the same way as the unfixed 
tumor cells. Colony counts from these cultures containing for-
malin-fixed tumor cells are presented in Figure 1 as open cir­
cles, showing no development of "colonies". Further data from 
this same culture showed no "colony" development up to 3 weeks 
after seeding of the formalin-fixed tumor cells. These data pro­
vide support for interpreting the growth curves presented here 
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Growth of rat prostate carcinoma cell line, 
MatLyLu, in soft-agar culture. In Figures 1-4, 
three curves are presented for each tumor: all 
colonies over 60 urn m diameter (Λ), all colo­
nies over 86 um in diameter (·), and all colo­
nies over 124 urn in diameter (D) . In addition, 
an aliquot of this tumor cell suspension was 
fixed with 10% neutral buffered formalin be­
fore plating in soft-agar (0). Each point 
with standard error bars represents two or 
more culture dishes. Standard error bars omit­
ted from day 13 points for visual clarity. 
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as representing real multiplication of cells during incubation 
after plating, rather than as artifacts of the agar culture sys-
tem . 
Of the 117 primary human tumors studied, 30 showed growth in the 
HTCS using two criteria: (1) presence of more than 20 colonies 
over 60 Aim in diameter at the peak of growth and (2) a maximum 
colony number at peak growth at least twice the day 1 count or 
twice the minimum count achieved after deterioration of clumps 
seeded into culture (see below). An additional 13 tumors showed 
growth in the HTCS by one or the other of the two criteria. 
Seventy-four tumors did not fulfill either criterion and thus 
were interpreted as showing no growth. 
Growth of primary human tumors in soft-agar culture presents 
several aspects not seen in the growth of cell lines. Figure 2a 
shows the growth of a breast carcinoma from pleural fluid. The 
development of colonies m soft agar is rapid with peak colony 
counts at day 7-11, but following the peak, the deterioration 
of colonies seen in cell lines (Fig. 1) is frequently absent 
or less dramatic, with a relatively long plateau of stable co-
lonies. This long plateau is seen best in Figure 2a for the co-
lonies ^ 86 /im and ^ 124 /am diameter. The relative predominance 
of colonies of smaller size is also more marked with primary 
human tumors. 
One of the most significant differences between human tumors 
and cell lines is the presence of significant numbers of clumps 
seeded into the agar. Figure 2a shows that more than 100 clumps 
exceeding 60 Aim in diameter were seeded into the agar. This fin-
ding correlates well with the cytologic appearance of a number 
of epithelial tumors growing m effusions or on the surface of 
cavities. These tumors grow as tight clusters of cells with 
nuclear and cytoplasmic molding and vague to absent cell bound-
aries, the appearance suggesting very tight bonding or even 
syncytium formation. This morphologic appearance is identical 
to that of human tumor colonies developing in soft agar cultu-
re, thus preventing reliable distinction between colonies de-
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veloping in culture and clumps seeded into culture if only a 
single time point of growth is evaluated. Examples of these 
tumors include breast and ovarian cancers growing in effusions 
and papillary transitional-cell carcinoma recovered from urine. 
Figure 2a demonstrates that growth of real tumor cell colonies 
can be recognized in soft agar using growth curves, even in the 
presence of significant numbers of clusters seeded into agar. 
Of the 117 tumors used in the present study,"Colony" counts 1 
or 2 days after plating showed that 43 tumors contained 0-10 
clumps over бОліт in diameter seeded into the agar. Forty-nine 
samples contained 10-100 clumps and 25 contained more than 100 
clumps seeded in the "single-cell" suspension. 
An alternative solution to the problem of clumps seeded into 
agar is demonstrated in Figure 2b. Because of the marked dump­
iness of the specimen shown m Figure 2a, an aliquot of the 
original cell suspension was further treated with trypsin diges­
tion (0.25% in 0.1% EDTA; Flow Laboratories) before being 
plated in agar. Although the trypsin did not significantly chan­
ge the percentage of trypan-blue-excluding cells, the growth of 
the tumor was significantly different from the growth without 
trypsin pre-digestion. The number of tumor cell clumps seeded 
into culture was markedly reduced. However, the time to peak 
colony growth was markedly prolonged: 24 days after trypsin 
compared with 11 days without trypsin. In addition, the growth 
of larger colonies ( } 86 um diameter) was almost completely 
eliminated by trypsin treatment. 
A similar phenomenon is seen in Figure 3 from an ovarian cysta-
denocarcinoma cultured from peritoneal irrigation fluid. Figure 
3a demonstrates that a large number of clusters were seeded in­
to culture. However, by assessing "colony" counts at multiple 
time points, deterioration of these clumps over 3 weeks could 
be recognized. Finally at 3 weeks, real growth of tumor-cell 
colonies could be demonstrated with subsequent deterioration 
of the colonies over the following 2 weeks. Trypsin pre-diges-
tion of the same single-cell suspension (Fig. 3b) markedly re­
duced the number of clumps seeded into the agar as well as the 
total number of colonies developed in all three size categories, 
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cussion" 
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However, in contrast to Figure 2a and b, the time to maximum 
colony growth was not altered by the trypsin treatment, being 
22-26 days after plating of the tumor in both cases. 
A morphologic difference between clumps seeded into culture and 
colonies developing in agar was suggested by study of the PAS-
stained agar layers of this tumor. The clumps demonstrated 
early m culture (Fig. 3a, days 1-15) showed a morphology simi­
lar to paraffin block material from the original tumor with ho­
mogeneous, relatively dense cytoplasm. In contrast, the colo­
nies developing m agar (Fig. 3a and b, later than day 22) con­
tained cells with foamy cytoplasm and nuclei, suggesting pha­
gocytosis of agar during growth. 
Patterns of colony growth after drug treatment: 
Twenty-five of the 117 tumors studied yielded enough cells to 
allow incubation of aliquots of the single-cell suspension with 
1 to 11 cytostatic drugs before plating in agar. Of these 25 
tumors, 14 also produced growth in the non-drug-treated (con­
trol) plates which met both criteria for growth as stated abo­
ve. From these 14 tumors, a total of 89 growth curves after 
drug incubation were obtained. Seventy-two of the 89 samples 
showed no effect of the drug on the time course of colony deve­
lopment. Seventeen growth curves showed some effect of the cy­
tostatic agent. The effects of drugs on the time course of 
tumor colony growth in vitro showed several patterns. Figure 
2c shows the development of colonies from the breast carcino­
ma shown in Figure 2a, following 1 h рге-incubation with 5-FU. 
Although clearly resistant to 5-FU, the tumor shows some res­
ponse to the drug in the delayed development of larger colonies 
(\ 86 um; ^ 124 um) compared with the control, non-incubated 
sample. Figure 2d shows tumor colony development from the same 
tumor following 1 h incubation with adnamycin. Colony develop­
ment to 11 days is similar to that of the control sample (Fig. 
2a) but then a rapid decline in colony count ensues, followed 
by a minor second wave of growth during the third week in cul­
ture. This rapid decline m colony count between 11 and 17 days 
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could be recognized in PAS-stained agar layers as a loss of 
density of the colonies due to necrosis. 
The real value of assessing growth dynamics in culture is sug­
gested by Figure 4, cultures of an oat-cell carcinoma growing 
as a skin metastasis. Figure Да shows a full growth curve of 
this tumor, demonstrating a lag phase of 5 days followed by 
rapid growth of colonies to a peak at 19 days and then a de­
cline in the number of counted colonies. Figure Ab-f shows ab­
breviated growth curves of this tumor for non-drug-incubated 
(b) and four drug-incubated (c-f) samples. It should be noted 
that samples used only for growth curves, that is plated di­
rectly after preparation of the single-cell suspension as in 
Figure 4a, and aliquots from the same cell suspension incu­
bated for 1 h before plating with McCoy's wash as a control 
for drug-treated samples as in Figure Ab, frequently showed 
quantitative and occasionally qualitative differences in the 
patterns of growth. When either day 15 or day 19 colony counts 
of this tumor were used, cis-platinum clearly showed no effect 
(Fig. Ac) while adriamycin was clearly effective in vitro 
( S 70% inhibition of colony growth compared with control; Fig. 
Ad). VM-26 showed a more disturbing pattern of colony growth 
(Fig. 4e). At day 15 the number of colonies after drug treat­
ment compared with control would be interpreted as showing 
drug sensitivity (^70% inhibition). However, the rate of co­
lony growth between days 15 and 19 was faster after VM-26 
treatment than in the control plates so that at day 19, in 
vitro drug sensitivity was no longer seen. A similar accele­
ration of growth between 15 and 19 compared with control was 
also seen in cultures incubated with sparsomycin, an experi­
mental drug under investigation in our institution (Fig. Af). 
Evaluation of tumor colony development in soft-agar over time 
may provide new insight into the human tumor cloning system 
(HTCS) and may in addition contribute to solving some of the 
problems identified in the clinical applications of the HTCS. 
The development of tumor-cell colonies of different sizes af­
ter plating in agar can be demonstrated (Figs. 1-A) with va-
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rying rates of growth to maximum number of colonies and some­
times with secondary growth periods (e.g. Fig. 2d). That this 
colony growth is real and not dependent on artifacts in the 
HTCS has been demonstrated (Fig. 1). The temporal pattern of 
growth of colonies in agar may yield additional information 
bearing on the expected behavior of the tumor in vivo (Kirkels 
et al., 1982) and also provide a more sensitive mechanism for 
recognizing tumor colony development as a way of monitoring 
patients after therapy (Herman et al., 1983a). However, there 
are frequently marked differences in growth dynamics between 
model tumor systems (Fig. 1) and primary human tumors (Figs. 
2-4). These differences suggest that modifications of the HTCS 
based only on results from animal tumors or tumor cell lines 
should be implemented with great caution and only after exten­
sive testing on primary human tumors. 
The fact that real tumor colony development in agar can be re­
cognized even when the tumor-cell suspension used for seeding 
the culture plates contain a significant number of clumps is 
potentially important (Fig. 2a,c,d; Fig. 3). However, this 
phenomenon demands further investigations for both practical 
and theoretical reasons. In practical applications of the HTCS, 
the fact that clumpy specimens may show different patterns of 
growth compared with pure single-cell suspensions (Fig. 2a,b) 
suggests that interpretations of in vitro chemosensitιvity re­
sults must be made with caution. Even monitoring of patients 
after therapy for persistent or recurrent tumor may produce 
different results depending on whether the starting cell sus­
pension contained clumps or not. 
From the theoretical viewpoint, the HTCS is based on a "stem-
cell" theory of tumor growth and the requirement that colonies 
developing in soft agar are the progeny of single tumor cells, 
that is, true clones (Mackillop et al., 1983). Clearly, the 
development of colonies m soft agar from specimens containing 
multi-cell spheroids introduces a fundamental change in the 
theoretical basis of the HTCS. Nevertheless, tumors in patients 
grow as aggregates of cells with ample cell-cell interaction. 
Thus it is not predictable whether in clinical applications of 
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HTCS the growth of tumor cell colonies from clumpy specimens 
will provide a better or poorer model on which to base deci­
sions concerning predicted in vivo drug response, prognosis, 
or tumor persistence or recurrence. In working further with 
this system, it should be remembered that the growth of tumor 
colonies from clumps may be produced by a very limited number 
of cell divisions, particularly in those specimens in which 
the colonies produced are of the smallest acceptable diameters 
(60-72 urn). Conceivably, "growth" might also be simulated by 
cell swelling so that clumps smaller than 60 urn diameter could 
increase their size to acceptable colony size by cytoplasmic 
growth alone without any cell divisions. 
Perhaps the most significant application of the tumor colony 
growth curves is the recognition of different patterns of 
tumor response to drugs. This is illustrated in Figure 5. If 
a tumor is evaluated for drug response in the HTCS, present 
practice dictates that the drug-treated growth is compared at 
some arbitrary time point (e.g. 3 weeks) with control (non-
drug-treated) growth. If growth at the chosen time point is 
30% or less of the growth in control plates, the tumor is 
considered as sensitive to that drug. However, as illustrated 
in Figure 5, there are several growth patterns in culture 
which could produce 70% growth inhibition at 3 weeks. The 
most favorable pattern is illustrated in curve A of Figure 5 
In this pattern, colony development in the plate has reached 
a plateau at 3 weeks after having a relatively slower rate of 
colony growth compared with the hypothetical control curve, 
the 45° line. A somewhat less favorable pattern of growth is 
seen in curve В where the colony growth does not reach a pla­
teau but the rate of colony development is slower than in the 
control cultures. However, very different patterns of colony 
development are seen in curves С and D where the drug incuba­
tion produces a lag phase in colony development, after which 
the tumor cell colonies begin to develop at the same (C) or a 
faster (D) rate compared with the control cultures. Growth 
curves analogous to these theoretical curves are suggested by 
actual data shown in Figures 2 and 4. It is far too early to 
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determine whether specific tumors show specific patterns of co-
lony growth dynamics or whether specific drugs cause reproduci-
ble changes in the temporal pattern of tumor growth in vitro. 
Considerably more experience with the use of growth curves in 
vitro must be accumulated before questions of this kind can be 
answered and the contribution of in vitro measurement of tumor 
growth dynamics to clinical applications of the HTCS can be 
évalua ted . 
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INTRODUCTION: 
The recent development of short-term culture, derived from re-
search on hematological malignancies, applied to human primary 
tumors (1) has offered the clinical laboratory the possibility 
of monitoring dynamic rather than static properties of human 
tumor cells. Specifically, the tumor cloning system (HTCS) ap-
plied to solid tumors by Salmon et al allows the growth in the 
two-layer soft agar system of tumor colonies from clonogenic, 
presumptive "stem" cells.(2,3) 
The first proposed application of this system was the in vi-
tro determination of chemotherapeutic sensitivity or resistance 
of tumors to allow individualizing of chemotherapeutic regimens. 
(2) Further clinical applications have been proposed, including 
post-therapy evaluation of persistent or recurrent tumor (4) 
and evaluation of grade and stage of tumor, based on in vitro 
growth characteristics.(5,6) 
The first goal of the study presented here was to determine the 
value for clinical management of patients with transitional cell 
carcinoma and renal cell tumors who were to be treated with cy-
totoxic drugs for metastatic disease or in case of superficial 
transitional cell carcinoma of the bladder with intravesically 
applied cytotoxic drugs to prolong the recurrence free interval 
after transurethral resection of the tumor. In other words can 
the sensitivity or resistance to cytotoxic drugs of these tumors 
be predicted with sufficient accuracy with the in vitro tumor 
clonogenic cell culture system and can the management of the pa-
tients be improved by application of this laboratory test method? 
MATERIALS AND METHODS: 
We used the two-layer soft agar method (3) in the Dept. of Patho-
gy in the Radboud Hospital. Routine surgical specimens of solid 
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tumors were brought sterile and unfixed to the Dept. of Patho­
logy. Using sterile technique, a pathologist examined the ma­
terial and chose tissue for soft agar culture (approximately 
1-2 gr) and routine histopathologic study. In case of trans­
urethral resected bladder tumors the tissue for soft agar cul­
ture was chosen in the operating room during resection, mostly 
the exophytic part of the tumor. The material was brought to 
the Pathology Dept. within minutes. Care was taken that enough 
гергеыепtati ve tumor tissue was left for his topathology. Tissue 
selected for soft agar culture was further processed according 
to the detailed description recently published.(2) In brief, 
the tissue was minced with scissors for 5-10 minutes through 
a metal sieve of approximately ten holes per centimeter into 
McCoy's wash medium, later the tumor tissue was minced in a 
centrifuge tube with double blunt scissors. The cell suspeti-
sion with the tumor mince was incubated for 2 hours with a 
mixture of collagenase type II (Worthington) and DNAase type I 
at 37°C and 6% C0_.(7) After incubation, McCoy's wash was 
added and the cell suspen ¡on passed through a gas-sterilized 
nylon filter with 70-100 urn holes (Ortho Diagnostics, Belgium). 
The cells were then washed again and the cell pellet resuspen-
ded in 2-5 ml McCoy's wash according to the estimated number 
of cells. Trypan blue excluding cells were determined using 
0.1 ml of the cell suspension. The concentration of large 
nucleated cells was determined in a haemocytometer and then 
adjusted to 3x10 cells per McCoy's wash. For in vitro drug 
testing, cells were incubated for 1 hour in drug solutions 
prepared in NaCl 0.9% or water as required for the specific 
drug and diluted in McCoy's wash. Drug concentrations were 
approximately 10% of the in vivo attainable peak plasma 
level. (3) The cells for the control group were incubated 
with McCoy's wash alone, without a cytotoxic drug. After 
incubation the cells were centrifuged and seeded in 35 mm 
culture dishes with 5x10 cells per culture dish in double 
layer soft agar exactly as described elsewhere (2), except 
that conditioned medium was not used. The cultures were then 
incubated at 370C 6% CO» in a humidified atmosphere. 
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ALTERNATIVE SOURCES OF TUMOR CELLS FOR CULTURE: 
In an attempt to obtain good quality tumor cells for culture 
with minimal trauma to the patient we tried to culture tran-
sitional cell carcinoma colonies from urine specimens of pa-
tients with transitional cell carcinoma collected before 
transurethral tumor resection was star ted . (5 , 6 ) The use of 
effusions and irrigation fluids had previously been reported 
(8,9,10), however, culture of tumor cells derived from urine 
samples had not yet been published. Growth results from 
urine samples were comparable with cultures of solid tumor 
samples of TCC. Only the numbers of colonies produced in cul-
tures of cells derived from urines were not sufficient 
to test cytotoxic drugs where at least 30 colonies had 
to be grown in the control dishes. But the possibility to 
culture transitional cell tumor colonies from urine, which 
can be collected easily and repeatedly without much incon-
veniece for the patient, is the bases for an additional 
application of the soft agar tumor cell culture system that 
will be discussed later. 
COLONY COUNTING PROCEDURES: 
Colony counting plays an important role in the quantification 
of the tumor cell colonies in culture. Initially, colony 
counting was performed with an inverted microscope, a time 
consuming procedure, which lacks reproducibility. When an 
automated tumor colony counter (Omnicon Feature Analysis Sys-
tem II, Bausch and Lomb Inc., Rochester NY, U.S.A.) became 
available we started investigations on reproducibility and 
accuracy of this system.(11) The theory and operation of 
this instrument has been published.(12) The instrument used 
in our laboratory was similar to that previously described 
except that it was fitted with an inverted microscope and a 
fully automated 36-dish microscope stage. This allowed 
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walk-away operation with counting of 36 culture dishes taking 
an average of 40-45 minutes. 
For determination of within day rum-to-run reproducibility, 
sets of 36 glutaraldehyde fixed culture dishes were counted 
twice in succession with no change in position of the dishes, 
settings of the instrument controls etc. For determination 
of day-to-day reproducibility, the fixed culture dishes were 
counted 5 times on 5 or 6 different days over a period of 8 
days with demounting and remounting of the dishes as well as 
readjustment of the illuminator source and scanner sensiti­
vity each day. Duplicate Omnicon counts on the same day, 
showed a modal correlation coefficient (г) У 0.990; the 
median was^ 0.985. The modal day-to-day r value of automated 
colony counting was у 0.990 and the median r у 0.980. The 
distribution of run-to-run and day-to-day г values showed 
considerable left skewness. The coefficient of variation 
(c.v.) for each culture plate counted on 5 or 6 days was 
evaluated individually. The nodal c.v. was 6%, the median 
c.v. 10%, and 61 of 79 évaluable culture dishes showed a 
c.v. of automated counting less than 20%. Comparing the 
mean number of colonies per dish with the c.v., a tendency 
was seen to lower c.v. with higher colony counts. 
The reproducibility of manual counting was assessed by com-
paring the intra- and inter-observer variability. Great dif-
ferences were seeen between the results of colony counting 
by 3 observers. Intra-observer reproducibility varied from 
r = 0.943 to r = 0.733. Inter-observer reproducibility 
varied from г = 0.831 to r = 0.478, suggesting that results 
from 2 different observers in one laboratory can not be 
reliable compared, and even greater differences can be ex­
pected for comparison of results of two different laborato­
ries counting colonies and publishing their results. 
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EVALUATION OR GROWTH IN CULTURE: 
Automated instead of manual counting and sizing of tumor colo-
nies growing in soft agar allows accurate and reproducible ana-
lysis of the in vitro growth dynamics of tumor colonies. (11,13) 
This analysis demonstrated differences in the time course of 
tumor response to cytostatic agents as well as differences in 
the time course of development of various sizes of colonies 
from tumors of the same histologic type. The routine use of 
tumor colony "growth curves" (see fig. 1 and 2) may decrease 
the relatively high false positive rate of soft agar culture 
measurement of tumor drug sensitivity. In addition, the tempo-
ral pattern of the tumor colony development in agar may provide 
valuable new information on the prognosis of individual tumors. 
RESULTS: 
In the study here presented 64 évaluable samples are included, 
obtained from 39 patients with transitional cell carcinoma and 
14 samples of renal cell tumors obtained from 14 patients. 
The results from soft agar culture of human transitional cell 
carcinoma tumor colonies from urine, irrigation fluid and 
tumor samples are shown in table I, using the Omnicon FAS II 
automated colony counter for colony development evaluation. 
Growth in culture is described with "growth curves" from con-
trols (non drug treated cultures) and drug pretreated cultures 
for drug sensitivity testing. Table I shows the growth results 
of 64 samples that were évaluable, obtained from 39 patients. 
Infected cultures and cultures not évaluable because of poor 
quality of the culture dishes are not included. 
Twenty-seven of 64 samples (42%) showed growth which means 
that 2 criteria were met, arbitrarily chosen for growth 
evaluation. These criteria are: 1. presence of more than 20 
colonies over 60 urn diameter at peak of growth and 2. a maxi-
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mum colony number at" peak growth at least twice the day one 
count or twice the minimum count achieved after deterioration 
of clumps seeded in to culture. 
TABLE I. GROWTH OF TRANSITIONAL CELL CARCINOMA IN SOFT AGAR 
CULTURE. 
Growth curves based Growth curves based 
upon colony develop- upon colony develop­
ment in 2Д culture ment in 1-3 culture 
dishes.* dishes.** 
growth growth growth growth 
pos . neg . pos . neg . 
urines 23 7 7 
irrigat ion 
fluids 19 5 7 
urine + 
irrigation 
fluids 2 1 
tumor 
samples 20 10 10_ 
total 64 23 24 4 13 
* For every time point 2 dishes were removed from culture 
and colony number determined without reincubation of the 
dishes.(see fig. 1) 
** At regular time intervals the dishes were sealed with 
porous adhesive tape to prevent infection, the number of 
colonies counted and the plates reincubated after colony 
counting. 
*** For growth criteria see text below. 
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As shown in fig. 1 this growth curve is growth positive. Some 
other facts are illustrated in this growth curve which are al-
most general in this type of culture. Firstly, at day one co-
lonies are counted, which is not very likely to be true. The 
structures counted at day 1 are most likely to be clumps 
seeded into culture. This has major implication on the colony 
development. In the case clumps are plated, growth in soft 
agar culture is not clonal as it would be if an absolute sin-
gle cell suspension could be plated. It has been posed that 
no growth in culture is possible if only single cells are 
plated in the culture dishes.(14,15) This means that eventual-
ly the growth obtained in the culture system is not derived 
from real "stem" cells but possibly originates from clumps 
of cells with limited reproductive potential.(16) With only a 
small number of cell divisions the size criteria of a colony 
may be reached. What impact these theoretical considerations 
have on the evaluation of drug sensitivity testing with "clo-
nogenic" assays has to be determined.(13) 
Secondly, the lag time in colony development is apperent, fol-
lowed by a logarithmic growth phase. If the sensitivity test 
is evaluated too early, erroneous results would be obtained. 
Thirdly, the large interplate variability is shown, described 
by the standard error values. This interplate variability 
will make the evaluation of a drug test more difficult. 
A total of 10 samples, 5 tumor samples, 4 irrigation fluids 
and 1 urine sample, yielded enough cells for cytotoxic drug 
testing, 1-4 drugs were tested. One tumor sample showed his-
tologically no transitional cell carcinoma, only atypia of the 
cells; this sample showed no growth in culture. One irrigation 
fluid culture was lost for evaluation due to infection. 
Of a total of 29 évaluable growthcurves of drug pretreated 
cells no significant growth inhibition was obtained. Drugs 
tested, were cisplatin, adriamycin, 5-fluorouracil and metho-
trexate . 
n o 
I i g u r e 1 
number of colonies 
mean (se ) pT, Gri 2 ТСС (pyelum) 
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For each time point the mean and S.E. of colony counts 
of 2 dishes are shown. 
The upper line shows all colonies over 60 urn in dia-
meter, the middle line all colonies over 86 urn in dia-
meter and the lower line all colonies over 124 um in 
diameter. 
As shown in fig. 2 some drugs caused growth stimulation com-
pared with growth in the control dishes. What impact this 
stimulation in vitro has in vivo, if the patient is treated 
with this drug, is not yet clear. Probably it is best not to 
treat the patient with the drug which showed stimulation in 
vitro. 
F i g u r e 2 . 
number of colonies 
mean (s.e.) 
60-
рТзбгз ТСС 
control 
19 22 26 29 
Growth m conLi-ùi cultures (upper growth curve) 
and drug pretreated cultures after 1 hour 
exposure to cisplatin at 10% of the in vivo 
achievable peak plasma concentration (lower 
growth curve) . 
The growth results of 14 renal cell tumors are as follows. 
Eight out of 14 samples (57%) showed colony growth in soft 
agar culture, according to the criteria described above. Ten 
samples yielded enough cells for in vitro cytotoxic drug 
testing; 4-9 drugs were tested, with a total number of 55 
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drug tests. Thirteen of these 55 drug tests showed some growth 
inhibition which was not significant. 
Until now it was not yet possible to make any in vitro in 
vivo correlations because none of the patients from whom tumor 
samples were obtained and tested with cytotoxic drugs had me-
tastatic disease, needing systemic cytostatic treatment. 
It can be concluded from our experiences that cytotoxic drug 
sensitivity testing on transitional cell carcinoma and renal 
cell tumors cannot be routinely applied to all patient's 
tumors. The low growth potential and the low cell yield make 
it impossible to test cytotoxic agents on all samples. 
The lack of effective cytotoxic agents against renal cell 
tumors makes it difficult to identify a drug that shows sen-
sitivity in vitro. For clinical application, the long culture 
period needed to obtain sufficient growth, if growth is deve-
lopment at all, is a major roblem for clinicians who want 
to start chemotherapy as soon as possible after the operation 
and diagnosis. 
Additional applications of the soft agar culture system are 
the follow-up investigation of patients during and after in-
travesical chemotherapy or radiation for transitional cell 
carcinoma of the bladder. Patients with apparently no tumor 
in the bladder showed positive growth curves from cells ob-
tained from urine samples, during and after therapy. Some 
patients already developed recurrences, another group of 
patients had positive urine growth curves but did not yet 
develop recurrences. Our hypothesis is that this group has 
a higher risk to develop recurrences than the patients with-
out positive growth curves. Prospective randomized studies 
have to be performed to determine if this follow-up inves-
tigation will provide an improvement of patient treatment. 
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Another application of the soft agar culture system is the 
grading of the malignant characteristics of transitional cell 
carcinoma and renal cell tumors not only based on morphologic 
investigations but additionally by determination of the biolo­
gical properties of the tumors with growth curves, to predict 
the growth potential in vivo and metastatic behaviour in the 
future of the tumors under investigation. 
In conclusion, the soft agar culture system is valuable as an 
investigational tool to learn about biological properties of 
tumors. The initially proposed routine laboratory test for 
cytostatic drugs on all patient's tumors meets with practical 
and theoretical problems, which make the Lest not practicable 
in a routine laboratory setting. 
ACKNOWLEDGEMENTS: 
The author would like to thank Bausch and Lomb Inc., Rochester, 
NY, U.S.A. for the use of the Omnicon FAS II. Supported in part 
by a grant from the Netherlands Cancer Society, Queen Wilhelmi­
na Fund . 
REFERENCES: 
Hamburger AW, Salmon SE. Primary bioassay of human tumor 
stem cells. Science 1977: 197; Д61-463. 
Salmon SE, Hamburger AW, Soehnlen BS, Durie BGM, 
Alberts DS, Moon TE. Quantification of differential sen-
sitivety of human tumor stem cells to anticancer drugs. 
N Eng J Med 1978: 298; 1321-1327. 
Salmon SE (editor). Cloning of human tumor cells. 
Progress in clinical and biological research, Vol. 48. 
Alan R. Liss Inc., New York, 1980. 
Herman CJ, Pelgrim OE, Kirkels WJ, Debruyne TMJ, Vooys GP. 
"Viable" tumor cells in post-therapy biopsies: an application 
of human tumor clonogenic cell culture. Arch Path Lab Med 
1983: 107, 81-83. 
Kirkels WJ, Pelgrim Ob, Debruyne FMJ, ооуь GP, Herman CJ. 
Soft agar culture of human transitional cell carcinoma 
colonies from urine. Am J Clin Pathol 1982: 78; 690-694. 
Kirkels WJ, Debruyne FMJ, Pelgrim OE, Vooys GP, Herman CJ. 
Soft agar cultures of transitional cell carcinoma colonies 
from urine, irrigation fluid and tumor samples. Eur Urol 1983: 
9; 300-304. 
Slocum HK, Pavelic ZI,, Rustum YM, Creaven PJ, Karakousis CK, 
Takita H, Greco WR. Characterisation of cells obtained by 
mechanical and enzymatic means from human melanoma, sarcoma 
and lung tumors. Cancer Res 1981: 41; 1428-1434. 
Buick RN, Stanisele TH, Fry SE, Salmon SE, Trent JM, 
Krasovich P. Development of an dgar-methy1-cellulose clono­
genic assay for cells in transitional cell carcinoma of the 
human bladder. Cancer Res 1979: 39: 5051-5056. 
Ozols RF, Willson JK , .rotzinger KR, Young RC. Cloning of 
human ovarian cancer cells in soft agar from malignant 
effusions and peritoneal washings. Cancer Res 1980: 40; 
2743-2747. 
Stanisele TH, Buick RN. An in vitro clonal assay for bladder 
cancer: clinical correlation with the status of the urothe-
lium in 33 patients. J Urol 1980: 124; 30-33. 
Herman СJ, Pelgrim 0E, Kirkels WJ, Verheyen R, Debruyne FMJ, 
Kenemans P, Vooys GP. In-use evaluation of the Omnicon auto­
mated tumor colony colony counter. Cytometry 1983: 3; 439-442. 
Kressner BE, Morton RRA, Martens AE, Salmon SE, VonHoff DD, 
Soehnlen B. Use of an image analysis system to count colonies 
in stem cell assays of human tumors. In : Salmon SF (editor) 
Cloning of human tumor stem cells. New York, Alan R. Liss 1980 
pp 179-193. 
Kirkels WJ, Pelgrim 0E, Hoogenboom AMM, Aalders MW, Debruyne 
FMJ, Vooys GP, Herman СJ. Patterns of tumor colony development 
over time in soft agar culture. Int J Cancer 1983: 32; 399-406. 
115 
14. Agrez MV, Kovach JS, Lieber MM. Cell aggregates in the soft 
agar human tumor stem cell assay. Br J Cancer 1982: 46; 
880-887. 
15. Selby PM, Buick RN, Tannock I. A critical appraisal of the 
"human tumor stem cell assay". N Eng J Med 1983: 308; 129-
134. 
16. Mackillop WJ, Ciampi A, Till JE, Buick RN. A stem cell model 
of human tumor growth: Implications for tumor cell clono-
genic assays. J Natl Cancer Inst 1983: 70; 9-16. 

CHAPTER 8. 
REPEATED URINE CELL CULTURE IN SOFT AGAR: 
POTENTIAL ROLE IN FOLLOW-UP OF PATIENTS WITH 
TRANSITIONAL CELL CARCINOMA. 
Wim J. Kirkels, Olga E. Pelgrim, Mathilde W. Aalders, 
Frans M.J. Debruyne, G. Peter Vooijs and 
Chester J. Herman. 
Departments of Urology and Anatomie Pathology, 
Radboud Hospital, Catholic University Nijmegen and 
Department of Anatomic Pathology, SSDZ, Delft, 
the Netherlands. 
Submitted for publication in 
the Journal of Urology. 
118 
ABSTRACT: 
To evaluate the persistence of cells with clonogenic properties 
in patients being treated for transitional cell carcinoma, 272 
urine samples were collected from 75 patients and cultured in a 
double layer soft agar "cloning" system. 
The development of colonies was evaluated with growth curves 
based on repeated colony counting with an Omnicon automated 
colony counter at regular time intervals. Forty-eight patients 
had at least one évaluable culture. Comparing the results of 
colony development in culture with the clinical evaluation of 
the patients, 9 patients had a histologically proven recurrence 
preceded or accompanied by tumor colony growth in urine culture. 
One patient had tumor recurrence with growth negative urine 
culture (false negative). Fifteen patients have had growth 
negative urine culture with a negative follow-up (mean 19.5 mos.), 
Twenty-one patients have had growth positive urine cell cultures 
wiht no recurrence in thei follow-up (mean 18.7 mos.). 
Although the follow-up times are at present relatively short, 
the present study suggests that repeated soft agar urine culture 
of patients with low-grade, low-stage bladder carcinoma may 
provide a means for identifying those patients at a higher risk 
for recurrence / progression of their disease. 
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INTRODUCTION: 
Superficial transitional cell carcinoma of the bladder is usually 
treated by local resection followed by intravesical chemotherapy 
(1). Post-therapy evaluation of these patients usually requires 
repeated urine cytologies, cystoscopies and transurethral 
biopsies. Because of the effects of therapy, cystoscopy and even 
cytology can be equivocal in evaluating the response to treatment 
and the development of recurrent disease. 
The use of the two layer soft agar culture as a means of evalua-
ting treated patients for persistent or recurrent tumor has 
recently been proposed (2). It has been shown that transitional 
cell carcinoma cells present in urine form colonies in this 
system (3,4) while normal urothelial cells do not grow (5,6). 
The present study was therefore designed to evaluate the potential 
utility of repeated soft agar culture of urine as a way of 
monitoring the status of the urothelium in patients treated for 
low-grade, low^stage bladder carcinoma. Since single time-point 
counting of colonies may be misleading (7), the present study 
uses growth curves of colonies developing in agar over 2-5 weeks 
as a way of evaluating the clonogenic properties fo transitional 
cells. Preliminary results suggest that soft agar culture may be 
a useful adjunct to other follow-up methods in identifying 
patients with recurrence of transitional cell carcinoma after 
therapy. 
MATERIALS AND METHODS: 
Seventy-five patients treated for transitional cell carcinoma 
were included in this study. These patients had been or were 
being treated by intravesical chemotherapy and were being 
routinely evaluated by urine cytology, cystoscopy and when 
indicated, transurethral biopsies. Also included in the study 
were 2 patients who received intravesical Adriamycin for 
persistent CIS, and 3 patients treated with external beam 
radiation for invasive (pT2-pTA) bladder carcinoma. 
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The patients were asked to come to the outpatient department with 
a full bladder and urine wab then collected into heat-sterili/ed 
polypropylene bottles in one of three ways: 1) by spontaneous 
voiding; 2) through a cystoscope sheath if the patient was under-
going a cystoscopy or 3) from catheterization if the patient was 
receiving intravesical chemotherapy. After collection, the urine 
samples were transported to the Pathology Department and proces-
sed as recently described in detail (3,4). 5x10 Cells were 
seeded per 35 mm culture dish in double layer soft agar. If fewer 
than 5x10 cells were available, all cells were seeded into one 
35 mm culture dish. The culture dishes were incubated at 370C, 
6% CO« in a humidified atmosphere for up to 5 weeks, to allow 
well-formed colonies to develop. 
All colony counting in the present study was performed using the 
Omnicon FAS II automated colony counter (Bausch and Lomb Inc., 
Rochester NY, USA). This instrument has been described m detail 
previously (8) and its operating characteristics reported (9). 
Colony counting was begun within 1-2 days after plating the cell 
specimen. Because most of uhe urine samples yielded only enough 
cells to plate one 35 mm culture dish, the dishes were counted 
once a week, and reincubatod after counting. To prevent airborne 
infection during counting, the culture dishes were sealed with 
porous tape. Occasionally, when enough cells were available to 
seed a series of culture dishes, a growth curve as routinely 
used in our laboratory was evaluated, removing 2 dishes from 
culture for each time point to determine the number of colonies 
starting the first day after plating without rei neubat ion . 
A growth curve was accepted as showing colony growth if it met 
2 criteria: 1) at least 90-100% increase in colonies comparing 
the day 1 colony count with a maximum colony count, or after an 
initial decrease, at least 90-100% increase above the minimum 
colony count and 2) a sustained consistent increase over time m 
the number of colonies. If the percent increase criterion was not 
met the culture was said to be growth negative. Tf the growth 
pattern was not consistent, the culture was said to be not évalu-
able. Most cultures that were considered growth positive showed 
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considerably more than 100% increase in colony number. 
After termination of the culture, detailed morphologic assess-
ment of the colonies as well as other cells and particles in 
the agar was carried out on agar layers removed from the cul-
ture dishes, mounted on standard glass slides (10) and stained 
with the Periodic Acid Schiff (PAS) reaction. 
RESULTS: 
272 Urine samples were collected from 75 patients. 27 Patients 
were not further évaluable because of infections in culture or 
other technical reasons (see table 1). 
Of the 48 évaluable patients, 32 had at least one culture that 
showed colony growth: 16 patients had no growth positive cul-
tures. The day 1 counts of 81% of 54 growth positive cultures 
were less than 30 "colonies". Conversely the peak counts of the 
growth positive cultures was above 30 colonies in 65% of the 
cultures (see table 2). 
In table 3, the results of the urine colony cultures are com-
pared with the clinical course or the patients. In group 1, 9 
patients are listed who developed a histologically proven re-
currence and in whom at least one urine culture showed growth. 
Eight urine samples that were growth positive were collected 
at a time when cystoscopy revealed a recurrence. Ten urine 
samples obtained from 6 patients were growth positive 1-6 months 
(1,2,2,5,6,6) before a diagnosis of recurrent TCC was made. 
Group 2 consists of 21 patients who have not yet shown evidence 
of recurrent disease. Group 3 consists of 1 patients who deve-
loped several recurrences, but the 2 évaluable urine cultures 
showed no growth. As can be seen in table 3, 9 of 11 cultures 
of this patients were not évaluable, primarily due to infection. 
Group 4 consists of those patients with only growth negative 
urine cultures and who had not developed a recurrence. 
Of the 30 in Groups 1 and 2, 16 had at least 2 évaluable cul-
tures. The second culture was also growth positive in 14 of the 
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Tabic 1. 272 urine cultures from 75 patients with 
transitional cell carcinoma. 
TOTAL EVALUABIE* NOT EVALUABLE 
PAllbNTS: 75 48 27 
CULTURES: 
not evaluable-^S 68 25 
infected 72 42 30 
growth pos. 58 58 
growth neg. 49 49 total 272 217 55 
* These patients had at least one évaluable culture. 
^Not évaluable cultures: 
-degeneration of agar layers 
-lack of multiple time points for counting 
-no consistent pattern in the growth ( see methods ) 
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16 patients, suggesting reasonable reproducibility. 
The duration of follow-up after the last transurethral resec-
tion of a histologically proven TCC is 18.7 months + 14.5 
(mean + SD) for group 2 and 19.5 months + 15.1 for group 4, 
not significantly different. This similarity in duration of 
follow-up suggests that the development of recurrences in 
group 4 compared with group 2 is not due merely to differences 
in follow-up time after the initial diagnosis of TCC treated 
with transurethral resection. 
Omitted from table 3 are 2 patients each of whom had one posi-
tive urine culture but who have been lost for follow-up. 
In those urine cultures that showed growth by the criteria lis 
ted in Materials and Methods, the PAS stained agar layers con-
tained structures which could be recognized as tumor cell co-
lonies of transitional cell carcinoma (cf Herman et al,(2)). 
The comparison of the growth results and the results of cytolo 
gical investigation of urine samples shows that in all patient 
groups most of the cytology results reported atypia of the eel 
found in the urine (group 1:3/4; group 2:18/22; group 3:2/2; 
group 4:9/12). The other 8 cytology specimens of a total of 40 
were suspicious for, but not diagnostic of malignant lesions. 
DISCUSSION: 
The follow-up of patients with bladder cancer who have receive 
treatment other than radical cystectomy remains a difficult 
problem. The natural history of the disease is variable and 
patients with similar grade and stage of tumor may show marked 
ly different clinical course. The least invasive follow-up 
technique, urine cytology, is frequently indecisive as a guide 
to further management. 
124 
Table 2. Colony counts of growth positive cultures 
on first day after plating, at minimum number 
(see text) and at peak of colony growth. 
colony 
numbers 
0-5 
6-30 
31-100 
101-
day 1 
count 
12 (22%) 
32 (59%) 
9 (17%) 
1 ( 2%) 
54 
mini mum 
count 
16 (30%) 
29 (53%) 
8 (15%) 
1 ( 2%) 
54 
peak 
count 
0 
19 (35%) 
19 (35%) 
16 (30%) 
54 
¡^ Table 3. Comparison of urine culture colony growth and the 
clinical course of 48 évaluable patients. 
Histologically proven 
diagnosis of recurrent 
ТСС/CIS after TUR. 
No recurrenc after 
TUR of TCC. 
GROUP 1. (1) GROUP 2. (2) 
at least one 
cell culture 
growth positive 
9 patients (1-10 cultures, 
4.3 ± 2.5*) 
follow-up 12.6 ± 10.5 mos.* 
21 patients (1-12 cultures, 
5.1 ± 3.5*) 
follow-up 18.7 ± 14.5 raos.* 
GROUP 3 (3) GROUP 4 (4) 
no growth 
positive urine 
cell cui ture 
1 patient (11 cultures) 15 patients (1-8 cultures, 
3.7 ± 2.6*) 
follow-up 19.5 ± 15.1 mos.* 
Duration of follow-up periods of groups 1, 2 and 4 are not significantly 
different ( Student's t-test). 
* mean ± S.D. 
(1) Total of 24 évaluable cultures from 9 patients: 19 growth positive, 5 negative. 
(2) Total of 51 évaluable cultures from 21 patients: 39 growth positive, 12 negative, 
(3) Total of 2 évaluable cultures from 1 patient: 2 growth negative. 
(4) Total of 28 évaluable cultures from 15 patients: 28 growth negative. 
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Soft agar culture of urothelial cell tumor colonies from 
bladder irrigation specimens has been shown to correlate with 
the general status of the urothelium (6) and the risk of tumor 
recurrence (11,12). Recently, we have shown that transitional 
cell carcinoma cultured from urine forms colonies in soft agar 
(3,4). Normal transitional cells do not show growth in this 
system (5). We have further suggested that the use of soft agar 
culturing may provide a means of identifying persistent of 
recurrent disease in tumor patients after treatment (2). The 
present study is the first attempt to demonstrate the applica-
tion of this method. 
In this series, only 48 of 75 (64%) patients provided évaluable 
soft agar urine cultures. Although disappointing, this percen-
tage is not out of Line with the results obtained from routine 
bacteriological cultures of blood from patients with endocar-
ditis or other infectious illnesses caused by fastidious micro-
organisms . 
Nevertheless, routine bacteriological cultures are well accep-
ted as important clinical laboratory tools. 
Of the 48 évaluable patients, 9 patients showed tumor colony 
growth in soft agar. In 6 of these patients, the positive cul-
tures preceded histological proof of recurrence by up to 6 
months. Conversely, only one of the 48 patients showed false 
negative urine culture, developing tumor recurrence after 2 
negative urine cultures. 
The remaining patients provide a more interesting group. 
Twenty-one of these patients have shown at least one positive 
urine culture while 15 patients have had no positive urine cul-
tures. All of these 36 patients remain disease free after mean 
follow-up times of 19 and 20 months respectively. Although 
these follow-up times are short in the context of the natural 
history of transitional cell carcinoma, longer follow-up of 
these patients eventual prospective clinical trials should ans-
wer the question whether repeated soft agar culture of urine 
can identify a subpopulation of transitional cell carcinoma 
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patients at significantly higher risk for tumor recurrence 
and/or progression. 
This method of patient follow-up after therapy may also be of 
value in other tumors. Non-seminomatous testis tumors which 
present with bulky retroperitoneal disease are frequently 
treated by retroperitoneal lyphe node dissection after chemo­
therapy. The demonstration of clonogenic tumor cells by soft 
agar culture, persisting after chemotherapy in these patients 
as well as assessment of the persisting tumor's growth dynamics 
in culture could provide information useful to planning further 
therapy. 
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CHAPTER 9. 
GENERAL DISCUSSION. 
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DISCUSSION: 
The first goal ot the present study was to evaluate the 
possibility to culture transitional cell carcinoma in the double 
layer soft agar system. Because of the opportunity to compare 
our results with other major laboratories, we decided to follow 
the original protocol as described by Salmon. (1) 
For the preparation of single cell suspensions of solid tumors 
we chose the protocol of blocum, using Collagenase type II and 
DNase. (2) 
For morphologic studies of the colonies formed in agar we made 
preparations on slides according to Salmon. (3) 
Our first results showed the possibility to culture transitjonal 
cell carcinoma colonies from resected bladder tumor material, 
chapter 2 and 3, comparable with the results of others. (4) 
Seventy-seven percent of the transitional cell carcinoma tumor 
samples showed growth (defined as development of at least 5 
tumor cell colonies). For an eventual cytotoxic drug sensitivity 
test at least 30 colonies had to be grown in control culture 
dishes, according to the criteria suggested by the Arizona group. 
Only 28% of our évaluable cultures of solid tumors showed this 
number of colonies, a percentage lower than that achieved by 
others culturing solid tumors. (4,5) Von Hoff published results 
on 510 tumors of which 372 tumors (73%) formed colonies. In that 
study, the percentage of tumors with more than 30 colonies per 
dish was not reported. (6) Benard reported 47% growth positive 
cultures (more than 5 colonies), but very few tumor samples grew 
enough colonics tor drug sensitivity testing. (7) Kern cultured 
more than 1000 tumors, of which 68% produced at least 30 colonies. 
Tumor cells were cultured in а СЬМ medium instead of the original 
double enriched McCoy's 5A bottom layer and the double enriched 
CMRL 1066 for the top layer. (8,9) Bertelsen reported 1582 assays 
of which 68% produced more than 30 colonies per control plate. 
(10) 
The fact that in urine cytology well preserved cells were 
obtained suggested the possibility of culturing cells from 
catheter urine, or from spontaneously voided urine as an 
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alternative source of tumor cells. This would make it easier to 
obtain transitional cell carcinoma cells for culturing purposes, 
with little or no problem caused to the patient who would not 
need to undergo any invasive procedures. As we have found, it 
is possible to culture· cells firom urine although the overall 
production of colonies is lower than with solid tumor specimens 
(chapters 2 and 3). 
Culture of tumor cells from irrigation fluids of the bladder 
showed overall results which were slightly worse than from urine 
tumor cell cultures. The growth results from bladder irrigation 
fluids were comparable with the growth results achieved by others. 
(11,12) 
In our experience, culturing transitional cell carcinoma of the 
bladder is attended by several problems, structural and 
theoretical. 
Tumors in the bladder are often small and multifocal. Preserving 
a representative part of tht: tumor material for histopathologic 
investigation makes it often impossible to obtain a large enough 
piece of bladder tumor material for culture. 
Furthermore, tumors in the bladder are often accompanied by 
bacterial infection (13) which makes soft agar culture of the 
tumor cells impossible because of bacterial overgrowth despite 
the antibiotics added to the culture media. Doubling the 
concentration of penicillin and streptomycin produced no 
improvement in infection rates. We thought it not wise to add 
more effective antibiotics because of development of resistant 
strains of bacteria in the laboratory and because of the risk 
of spreading infections, difficult to treat because f о resistance 
to antibiotics. 
Because of infected material approximately 25% of the samples 
for culture were lost before culture was started or, if the 
infection was not evident in the material presented for culture, 
during the incubation period of 3 to 4 weeks. 
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In the preparation of the tumor cell suspension that ultimately 
will be plated in the culture dishes, the total number of real 
tumor cells had to be determined. The cells were counted in a 
hemocytometer. In a wet, unstained preparation tumor cells had 
to be identified and counted in a total number of cells, often 
containing several times more inflammatory cells. This was often 
due to earlier intravesically administered chemotherapy resulting 
in a cystitis. We chose the criterion of large nucleated cells to 
be counted as tumor cells. This often gives rise to the problem 
of a total number of cells per dish that grossly exceeds 5x10 
cells per culture dish. (1) This excessive number of total cells 
plated has certain implications for growth, most likely decreased 
total growth due to early exhaustion of the culture media. Unfor-
tunately this effect was not measurable. Furthermore tumor cell 
counting lacked reproducibility due to differences in experience 
with judgment of cells in a preparation. 
Colony counting plays an important role in the evaluation of 
growth in culture. It is a very time consuming and poorly repro-
ducible procedure. Because of rather subjective criteria for 
tumor cell colonies, e.g. a three dimensional structure consis-
ting of more than 30 tumor cells; and the differentiation that 
is needed between pre-excistent clumps seeded into culture and 
colonies grown, colony counting by human observers is subject to 
error both within one laboratory and especially among different 
laboratories. Even if observers in one laboratory have the oppor-
tunity to come to a common opinion about colony evaluation, the 
inter-observer variability is not negligible, possibly due to 
attention, concentration and fatigue (chapter 5). 
In this context, investigations were undertaken to evaluate the 
performance of an automated colony counter, the Omnicon FAS II 
(Bausch and Lomb, Rochester, NY, USA) when the device became 
available in the Department of Pathology where this study was 
performed. 
A colony is in terms of this apparatus a smooth, round structure 
of homogenous density against the background and with a diameter 
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of at least 60 ^ im. In chapter 5 a detailed description is given, 
based upon our own experience and earlier data of Kressner (14). 
The reproducibility value (r) for the Omnicon, counting dishes 
twice on one day were: modal r value> 0.990 and median r value 
^ O ^ S S . The day to day colony counts on 5 subsequent days were: 
modal r value >0.990 and median г value )> 0.980. However, a 
considerable coefficient of variation (C.V.) was found depending 
on the number of colonies in a dish. There was a tendency to 
lower C.V. values with higher colony counts. 
Tn a separate experiment the question if the Omnicon counts 
artifacts, e.g. cracks and bubbles in the agar layers, as 
colonies was examined. It was shown that living tumor cells are 
needed in culture to achieve colony growth; if formalin fixed 
cells were seeded into culture no colonies were counted by the 
Omnicon (chapter 5). 
We concluded that the Omnicon FAS II automated colony counter 
is applicable for routine colony counting in the double layer soft 
agar culture system. 
Growth in culture is a dynamic rather than a static process. In 
an attempt to describe growth in culture quantitatively, the 
concept of growth curves was applied to this culture system as 
described in chapter 6. Growth patterns were in our opinion a 
possibility to deal with cultures in which clumps of tumor cells 
had been seeded (so the day one colony counts were not equal to 
zero). Growth of clumps seeded into culture into colonies, 
departs from the stem cell theory underlying the concept of the 
soft agar culture system. (15,16,17) 
Furthermore the low plating efficiency of the soft agar cultures 
means that many cultures can not be used for drug sensitivity 
testing. The description of growth patterns in cultures with 
growth curves offers a more sensitive method for evaluation of 
tumor cell colony growth and also for the evaluation of cytotoxic 
drug effects in soft agar culture. 
In our laboratory we changed over from single point colony 
counting as described originally and a 70% decrease m colony 
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numbers in the drug pretreated dishes as a criterion for sen­
sitivity, to the growth curve evaluation of cultures. Growth 
patterns were ultimately used to evaluate our cytotoxic drug 
sensitivity tests performed on transitional cell carcinoma. 
Results are described in chapter 7. In none of the cultures 
was drug sensitivity indicated with the soft agar culturing 
system. This can be expected because of the clinical resis­
tance of transitional cell carcinoma to many cytotoxic drugs. 
Also in another report, this chemoresistant picture in cultu­
re was found.(Д) It is noteworthy that Cisplatin, clinically 
used as a moderately active agent against transitional cell 
carcinoma did not show any growth inhibition in culture. In 
fact, Cisplatin caused in some instances growth stimulation. 
Elsewhere it is suggested that this drug resistance in culture 
may be due either to inappropriate incubation times of tumor 
cells before seeding into culture, or inadequate concentra­
tion because of incomplete knowledge of the pharmacodynamics 
of Cisplatin in culture media.(10) 
The value of drug sensitivity testing with an in vitro system 
such as the double layer soft agar system is measured by 
weighting the chance to identify an effective drug against 
an individual patient's tumor that would not be chosen by an 
experienced oncologist, making a choice based on retrospec­
tive and prospective clinical trials.(17,18,19,20) 
At this moment the role of soft agar tumor cell culture in 
choosing drug regimens for individual patients seems to be 
very limited. The favorable results presented by Von Hoff 
(21) and Alberts (22) were based on non-randomized clinical 
trials. Thus, randomized controlled prospective studies are 
still needed.(10) 
The double layer soft agar tumor cell culture system is in our 
opinion an important tool to study dynamic tumor biology, not 
only centered on studying inhibitory effects of cytotoxic drugs 
on growth but also to investigate if after therapy residual 
viable tumor cells can be found. As is described in chapter 4, 
the pathologist has to answer the question of residual viable 
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tumor cells after therapy based on the morphologic appearance 
of ccllb in histologic slides. However, we have demonstrated 
in culture that cells can keep their morphologic appearance 
which suggests viability without giving evidence of growth 
potential. It can be of importance for an oncologist to know 
if there were cells with growth potential in the residual tumor 
mass after therapy (chapter 4). 
This brings us to the question of selectivity of growth of 
malignant cells in culture or have certain benign cells also 
growth potential in soft agar culture9 In the earliest reports 
it was shown that inflammatory and connective tissue cells do 
not show growth in this culture system. (1) With increasing 
experience in all laboratories some benign cell types have been 
recognized that did show growth in this culture system, lor some 
cell types, this may represent pre-malignant properties in vivo. 
This will be difficult to determine because of the low incidence 
of this event. 
A synthesis of our ideas about tumor growth potential monitoring 
and using alternative sources for tumor cells for culture is 
described in chapter 8. Here we describe the first results of 
a study performed to evaluate the possibilities of the soft agar 
culture system to predict recurrences of transitional cell 
carcinoma during and after intravesical chemotherapy, before 
urine cytology and cystoscopy give definite evidence. 
Our first results offer the possibility of future studies using 
soft agar cultures to monitor and eventually predict in vivo 
behavior of cells with an apparently normal appearance with 
todays investigations. In this way ditf erentiation may be 
possible to select those patients who need more aggressive 
t rea traent. 
For future investigations, the double layer soft agar culture 
system can be used to study the clinical heterogeneity of 
transitional cell carcinoma (23) which was also identified in 
the soft agar culture system comparing drug sensitivity of tumor 
cells originating from different sites in one patient. (24) 
Isolated colonies grown in soft agar can be useful for further 
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investigations looking for differences in expression of 
cytoskeleton proteins. 
It may also be possible to culture the colonies grown in soft 
agar in an attempt to establish tumor cell lines originating 
from one tumor cell. 
We can conclude that the double layer soft agar culture system 
is a useful investigational tool for tumor biology of transi-
tional cell carcinoma. Drug sensitivity testing is still not 
possible in a routine set up for transitional cell carcinoma. 
Alternative sources for good quality tumor cells, urine and 
bladder irrigation fluid, were investigated with positive 
results. Growth pattern analysis has been described. 
For future application a more detailed description of growth 
curves will be needed. Possibly, more mathematical description 
of the growth curves can make this way of describing growth in a 
culture system more sensitive for changes with time, also those 
changes induced by drug incubation of the cells. 
The use of soft agar cell culture for the identification of 
patients with aggressive tumors or of patients who will readily 
develop recurrences during or after therapy is the most promising 
application for future investigations on the soft agar tumor cell 
culture system. 
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SUMMARY. 
SAMENVATTING. 
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SUMMARY: 
This study was undertaken to investigate the possibilities to 
test cytotoxic drugs in vitro on transitional cell carcinoma 
with the double layer soft agar culture system. First goal was 
to determine the practicability of this in vitro test system in 
a routine laboratory setting. 
We showed that in urine and bladder irrigation fluids from 
patients with a bladder tumor good quality tumor cells can be 
obtained for culture purposes. 
For colony counting an automated image analysis system became 
available in the laboratory of the Department of Pathology, 
the Omnicon FAS II (Bausch and Lomb, Rochester, NY, USA). This 
system was integrated in the laboratory routine after extensive 
studies on reproducibility. We concluded that the overall per-
formance of the Omnicon is more reproducible than the results 
obtained by human observers counting colonies. 
Because a more dynamic evaluation of tumor cell colony growth 
seemed to be more sensitive for changes in colony development 
in culture, we started to evaluate growth patterns with "growth 
curves". Theoretical advantages are described to advocate the 
use of growth curve evaluation of colony growth instead of 
single point colony counting as was described originally. 
We also concluded that tumor cell clumps seeded into the cultu-
re dishes can be evaluated for growth, but it is impossible to 
hold to the original concept of stem cells, single clonogenic 
cells, as a starting point of colony development. Theoretically, 
this change in concept will have major implications for cyto-
toxic drug testing with the double layer soft agar culture 
system. 
Our results of drug sensitivity testing on transitional cell 
carcinoma are disappointing. No growth inhibition was obtained 
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in 29 drug sensitivity tests. Drugs tested were Cisplatin, 
Adriamycin, 5-F1uorouracil and Methotrexate. The largest part 
of the tumor cell samples obtained for culture purposes yielded 
insufficient cells for the rather extensive number of culture 
dishes to be seeded for a growth curve evaluation. 
We have no data on the comparison of the in vitro drug resistance 
and the in vivo sensitivity or resistance of the tumors, because 
none oí the patients was treated with systemic chemotherapy. 
Additional applications for the double layer soft agar system 
were investigated. It seems possible to give an indication of 
viability of cells in a tumor specimen, based upon the growth 
potential under highly artificial growth circumstances as in 
the double layer soft agar system. The impact for the manage-
ment of a patient's tumor remains to be defined. 
As a synthesis of our ideas of viable tumor cells, growth evalu-
ation with growth curves and the use of urine as a alternative 
source for tumor cells we hu^e started a study to evaluate the 
value of repeated urine tumor cell cultures in the detection of 
those patients who will develop recurrences of their bladder 
tumor in the future. There was a relationship between growth in 
culture and the development of a recurrence. One group of 
patients showed growth in culture from urine tumor cells who 
have not yet developed a recurrence. These are the patients who 
need a very accurate follow up. The value of these findings has 
to be studied in prospective trials. 
In the study on the heterogeneity of bladder tumors, the tumor 
cell coloni nes can be used for further investigations. 
It can be concluded that the double layer soft agar culture 
system is a valuable tool for investigation in oncology. Further 
development and improvements of the technique, in combination 
with clinical trials are still needed. 
SAMENVATTING: 
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Deze studie werd gestart met als doel de mogelijkheden te onder-
гоекеп om met behulp van het "double layer soft agar tumor cell 
culture system" cytostatica te testen, werkzaam tegen het over-
gangscelcarcinoom van het urotheel. Het eerste doel was een 
antwoord te geven op de vraag of het in de praktijk mogelijk is 
dit testsysteem in een routinematige laboratorium opzet toe te 
passen . 
We hebben aangetoond dat uit urine en blaasspoelvloeistof van 
patiënten met een urotheelcelcarcinoom tumorcellen van voldoende 
kwaliteit verkregen kunnen worden voor kweekdoeleinden. 
Voor de telling van de kolonies kwam een volledig geautomatiseer 
beeldanalyse systeem, de Omnicon FAS II ( Bausch and Lomb Inc., 
N.Y., U.S.A.), ter beschikking in het laboratorium van de afde-
ing Pathologische Anatomie waar het onderzoek werd uitgevoerd. 
Dit systeem werd onderworpen aan uitvoerige studies naar de 
reproduceerbaarheid van de telresultaten, voordat tot invoering 
in het laboratorium werd overgegaan. De conclusie was dat de 
reproduceerbaarheid van de telling van kolonies door de Omnicon 
beter is dan de reproduceerbaarheid van de telling van kolonies 
door het laboratorium personeel. 
Omdat een dynamische evaluatie van de groei van kolonies gevoe-
liger lijkt voor geringe veranderingen in het verloop van de tijd, 
startten wij een evaluatie van groeipatronen in kweek met behulp 
van groeicurves. De theoretische voordelen werden beschreven die 
het gebruik van de evaluatie met groeicurves steunen, in plaats 
van de tot dusver gebruikelijke eenmalige telling van de kolonies 
Wij concludeerden eveneens dat in kweekschaaltjes waarin tumorcel 
klontjes werden opgebracht, evaluatie van de groei mogelijk is. 
De consequentie is wel dat onmogelijk aan het originele concept 
van "stamcellen", enkele, donogene cellen als startpunt van de 
ontwikkeling van kolonies kan worden vastgehouden. Theoretisch 
zal deze verandering van concept grote implicaties hebben voor 
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het testen van cytostatica met behulp van het "double layer soft 
agar culture systeem". 
Onze resultaten van de gevoeligheidstesten op het urothcelcel-
carcinoom waren teleurstellend. Er werd geen significante 
groeiremming geconstateerd in 29 cytostatica gevoeligheidstesten. 
De middelen die werden getest waren Cisplatina, Adriamycine, 
5-Fluorouraci 1 en Methotrexate. Het grootste deel van de tumor 
specimens voor kweekdoeleinden verkregen, leverden onvoldoende 
cellen op voor het grote aantal kweekschaaltjes dat nodig is voor 
een groei evaluatie met behulp van een groeicurve. 
Er kwamen geen data ter beschikking over de vergelijking van de 
in vitro resistentie in de in vivo resistentie of gevoeligheid 
van de tumoren voor de geteste cytostatica, want geen van de 
patiënten werd behandeld met systemische chemotherapie. 
Verder werden nog alternatieve toepassingen van het "double layer 
soft agar culture system" onderzocht. Het lijkt mogelijk een indruk 
te geven van de "viabiliteit" vna cellen in een tumorspecimen, 
gebaseerd op het groeipotentieel onder zeer kunstmatige omstan-
digheden voor groei zoals in het "double layer soft agar culture 
systeem". De implicaties voor de behandeling van patiënten dienen 
nog nader onderzocht te worden. 
Als een synthese van onze ideeën over viabcle tumorcellen, evalu-
atie van groei in kweek met behulp van groeicurves en het gebruik 
van urine als een alternatieve bron voor tumorcellen, zijn we 
gestart met een studie ter evaluatie van de waarde van herhaalde 
kweken van cellen uit urine van patiënten in de follow-up van 
een blaascarcinoom, voor de vroege detectie van die patiënten die 
met grote waarschijnlijkheid een recidief zullen ontwikkelen in 
de toekomst. Er werd een relatie geconstateerd tussen groei in 
kweek en het ontstaan van recidieven. Eén groep patiënten ont-
wikkelde gedurende de follow-up periode een recidief, waarbij 
eerder groei in kweek was geconstateerd, een andere groep patiën-
ten liet groei in kweek zien van tumorce1 kolonies, maar deze 
patiënten hebben nog geen recidief ontwikkeld. De verwachting is 
dat dit de patiënten ζ ij η die zeer nauwkeurige follow-up nodig 
hebben. De waarde van deze bevinding moet nog in prospectieve, 
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klinische studies verder worden geëvalueerd. 
Voor de bestudering van de heterogeniciteit van blaastumoren lijkt 
het mogelijk tumorcelkolonies te isoleren die voor verder onder-
zoek kunnen worden gebruikt. 
Concluderend kan gesteld worden dat het "double layer soft agar 
tumor cell culture system" een waardevolle methode is in het 
experimenteel oncologisch onderzoek. Verdere ontwikkeling en 
verfijning van de techniek zijn noodzakelijk evenals klinische 
trials om de waarde van de gevonden resultaten te toetsen. 
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STELLINGEN 
1. Het is logischer de vitaliteit van cellen te beoordelen 
op basis van het groeipotentieel in kweek dan op basis 
van de morfologie van de cellen in gefixeerde toestand. 
2. Laboratoriumbepalingen die gebaseerd zijn op subjectieve 
menselijke beoordeling zullen vervangen worden door objec-
tieve, kwantitatieve bepalingen. 
3. Een kolonie is zelden een kloon. 
4. De preliminaire publicatie van positieve resultaten van 
een nieuwe onderzoeksmethode wekt valse hoop bij ernstig 
zieke patiënten. Als er commerciële belangen in het spel 
zijn, geraakt een dergelijke methode voortijdig in discrediet. 
5. "Het zou de wetenschap ten goede komen wanneer meer aan-
dacht wordt besteed aan publicatie van negatieve resultaten" 
(Dr. R.C.Roozemond, G.U. Amsterdam, 1969) is een stelling 
die steeds belangrijker wordt. 
6. Iedereen geeft slagpijn aan op de nierloges. Kloppijn op de 
nierloges heeft een heel andere betekenis. 
7. Het inzagerecht van het medisch dossier kan een mondelinge 
uitleg aan de patient niet vervangen. 
8. Het gebruik van de waarschuwingsknipperlichten maakt een 
verkeersovertreding niet legitiem. 
9. Chest-X-ray films should not be ordered solely because of 
hospital admission. N.Engl.J.Med.,312 : 209-213, 1985. 
10. De voeten van diabetici worden ernstig bedreigd door de 
diabetische neuropathie waardoor geringe traumata niet 
worden opgemerkt en de slechte wondgenezing tengevolge 
van de trofische stoornissen door de diabetische neuro-
pathie en de diabetische angiopathie. 
11. Was eerder de promotie een afsluiting van een medisch 
wetenschappelijke carriere, tegenwoordig wordt het steeds 
meer een begin. 
Nijmegen, 19 april 1985. 
W.J. Kirkels. 


